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ABSTRACT

Statement of Problem: Opioid epidemic in United States has been, in part, linked to
prescribing practices of practitioners who treat chronic pain. The increase in morbidity and
mortality associated with widespread prescription of opioid pain relievers (OPRs) has been the
driving force in the reassessment of clinical prescribing guidelines. Given the enormity and
urgency of the problem, in 2016, the Centers for Disease Control and Prevention (CDC)
introduced guidelines for prescribing opioids to chronic noncancer pain to primary care
practitioners. The introduction of the clinical guidelines sparked much concerns from providers
and activist groups. There is little known in the literature relating to providers’ knowledge,
belief, attitudes relating to practices that utilize the 2016 CDC opioid guidelines for chronic pain.
Therefore, the purpose of this study was to explore and understand the relationships among
providers’ (physician, nurse practitioner and physician assistant) knowledge, belief, attitudes,
and practices regarding 2016 CDC opioid prescribing guidelines, A secondary aim of the study
was identifying the presence of mediating variable between knowledge and practice.
Theories: The constructs addressed in the study are knowledge, belief, attitude,
innovation, and practice adherence. The study is built upon a novel framework created by the
researcher based on well-established works of Diffusion of Innovation Theory (DOI) by E. M.
Rogers and Knowledge-Attitude-Practice (KAP) model. Integrated elements of both theories are
supporting pillars of the study.
Methods: The design was descriptive, cross-sectional, and correlational utilizing
previously published quantitative survey tool (McCalmont et al., 2018). The sample consisted of
243 practitioners of 47 Physicians, 57 Physician Assistants and 55 Nurse Practitioners. A letter
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of solicitation was emailed through national professional organizations of American Academy of
Nurse Practitioners (AANP) and American Academy of Physician Assistants (AAPA).
Results: Survey respondents demonstrated varied knowledge recall of the 2016 opioid
prescribing guidelines. Knowledge was a statistically significant predictor of belief variable
(r= .294, p < 0.001). A statistically significant bivariate relationship emerged between belief and
individual attitude (r = .831, p < 0.001). Aligned with an increase on the belief scale, a provider’s
individual attitude scale score increased regarding implementation of the guidelines to improve
patient outcomes. Knowledge was a significant predictor of the Belief Scale,
Beta = .16, p = 0.002. As the knowledge variable increased, the belief variable also increased.
Knowledge was a significant predictor of the Individual Attitude Scale, Beta = .26, p < 0.001. As
knowledge increased, scores on the individual Attitude Scale increased. Knowledge did not
directly predict either of the practice variables (Practice Scale I or Practice Scale II).
Belief was a statistically significant predictor of Practice Scale I (harm reduction), Beta =
0.47, p < 0.001. As a provider’s belief increased, their Practice Scale (harm reduction) increased.
However, belief was not a predictor for Practice Scale II (using nonopioid modalities). Individual
attitude was a significant predictor of harm reduction, Beta = 0.20, p = 0.008. As individual
attitude increased, practicing attitudes of harm reduction also increased.
Individual attitude was a significant predictor of Practice Scale in using nonopioid modalities,
Beta = 0.56, p < 0.001. As individual attitude increased, a provider’s practice of using nonopioid
modalities also increased. The study concludes knowledge effects were completely mediated
through individual attitude and belief.
Conclusion: Complexity of pain requires multidisciplinary approach to management.
Multidisciplinary practitioners include providers from nursing, physician assistant and medical
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colleagues. All these practitioners have varied training philosophies and they share a common
practice of managing patients with chronic pain in the primary care arena.
Perceptions influence practices and thus further understanding of perceptions will better steer
practitioner guidance. Subjective construct of belief and attitude are interrelated, and they are
significant drivers of professional autonomous practice. This study signals that subjective
variable of belief and attitude have mediating effect and influence on acceptance and
implementation of guidelines and thus exploring subjective constructs through qualitative
methods may further illuminate participant characteristics, as barriers to guideline adoption.

Keywords and phrases: CDC Guideline, opioid epidemic, primary care management, guideline
adherence.
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CHAPTER I
INTRODUCTION
Background of the Problem
Chronic pain is a common complaint in primary care, and it is the top cause of disability
in the United States (Clark, 2002; Smith, Hopton, & Chambers, 1999). Primary care practitioners
treat nearly half of all chronic-pain patients through various modalities, including prescriptive
opioids (Clark, 2002). The pivotal event that spurred liberal opioid prescribing practices for pain
management started with the notion that narcotics rarely lead to addiction (Porter & Jick, 1980).
For decades that followed, health care providers, legislators and the pharmaceutical industry
cited this study for encouragement to treat pain with opioids. Since then, the use of opioid pain
reliever (OPR) for treatment of chronic pain in the United States has escalated dramatically and
beyond containment (Jones, 2013). Some common OPRs include hydrocodone and oxycodone;
hydrocodone usage has doubled, and consumption of oxycodone has increased by 500% (Jones,
2013). The overprescribing of OPRs has led to a concurrent increase in opioid misuse and
addiction, closely followed by an increase in opioid-related overdose fatalities (Dart et al., 2015).
The National Survey on Drug Use and Health (Hughes et al., 2016) concluded that
among individuals over 12 years of age, an estimated 97.5 million individuals (36.4% of the
population) used prescription opioids, and 12.5 million (4.7% of the population) misused
prescription opioids (Hughes et al., 2016). The increase in morbidity and mortality associated
with widespread prescription of OPRs has been the driving force in reassessment of clinical
prescribing guidelines. Given the enormity and urgency of the problem, in 2014, the Centers for
Disease Control and Prevention (CDC) added opioid-overdose prevention to the priority list of
the top five public health challenges (CDC, 2014).
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Approximately one third of primary care practitioners encounter chronic pain patients in
their practices (Gureje et al., 1998). Practitioners are overwhelmed and challenged to manage
chronic noncancer pain (CNCP) and lack access to pain consultants who offer comprehensive
pain care (Alford, 2016). Furthermore, the United States houses only 4,000 specialists certified
in pain management (Breuer et al., 2007). As a result of the limited number of pain specialists,
primary care providers treat most patients with chronic pain in the United States.
While primary care providers treat most of the chronic pain patients, they are challenged
with having little formal training in pain management and minimal guidance for best opioid
prescribing practices (Jamison et al., 2014). In 2016, the CDC released opioid prescribing
guidelines for CNCP, aimed to alert primary care practitioners and other primary health care
providers to the use of pharmaceutical management in treating chronic pain lasting longer than 3
months, excluding cancer pain and end-of-life pain care (Dowell et al., 2016). The intended
purpose of the 2016 CDC Guideline is to promote safe prescribing practices among primary care
providers while decreasing mortality associated with opioid-use disorder, thereby decreasing
subsequent deaths from opioid-related overdoses. The well-intentioned recommendations have
created some concern about the lack of user-friendliness and insufficiency in meeting the needs
of both patients and providers.
Statement of the Problem
It is evident that opioid related deaths have become a personal tragedy and an economic
burden to society. Attempts to rein the crisis through public initiatives have not shown an
impactful and measured solution. Legislative initiatives have laid the foundations for
accountability for health care providers and clinical guidelines have been released to provide
direction for prescribing practices. However, practitioners are resistant to easily adopting
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guidelines. The CDC 2016 guidelines relating to opioid prescribing has led to much outcry and
controversy for its prescriptive direction rather than suggestive guidance.
Need for the Study
Primary care practitioners are responsible for prescribing and treating most of chronic
pain patients utilizing all types of modalities including opioids. The primary care practitioners
have varied training backgrounds and experiences which may influence their treatment approach
and treatment philosophy. Therefore, further investigation of primary care providers’ perceptions
of the value and effectiveness of these guidelines is warranted.
Purpose of the Study
The purpose of this study was to investigate primary care providers’ knowledge, belief,
attitude, and practices of the 2016 CDC opioid prescribing guidelines relating to CNCP. Both
practitioners and prescribers caring for chronic-pain patients have a critical need to be aware and
understand the CDC Guideline and individual state mandates to best serve the chronic-pain
population safely and knowledgeably. To gain insight into healthcare providers' perceptions
related to the 2016 CDC Opioid Prescribing Guideline through knowledge, beliefs, attitudes
paradigm and its impact on practice will be useful in practically guiding policy makers to tailor
guidelines for greater adoption and adherence to the intended practitioner.
Theoretical Framework
The theoretical framework of this study is established by integrating two models,
Knowledge-Attitude-Practice (KAP) model and Roger’s Diffusion of Innovation Theory. The
constructs in E.M Roger’s Diffusion of Innovation Model, include innovation, communication,
and time while the constructs of KAP Model explain a linear relationship through three
constructs of knowledge, attitude, and practice. Combining elements of both frameworks and
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appreciating complexity of guideline adherence, a novel framework was created to include
elements of both frameworks discussed.
Research Questions and Hypotheses
To understand knowledge, attitudes, and practices regarding the adoption of CDC
Guidelines of 2016 opioid prescribing by primary care practitioners. A quantitative analysis was
chosen to investigate the proposed research questions.
RQ1. What is the relationship between the amount of provider’s post licensure training
relating to the area of chronic pain management (CPM) and:
a.

The provider’s knowledge of the 2016 CDC Guideline.

b.

The provider’s belief that that the 2016 CDC Guideline will reduce the epidemic
opioid crisis.

c.

The provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved outcomes in CPM.
HA1a: A statistically significant relationship exists between provider’s post

licensure training and the provider’s knowledge of the 2016 CDC Guideline.
HA1b: A statistically significant relationship exists between provider’s post
licensure training and the provider’s belief that that the 2016 CDC Guideline will reduce the
epidemic opioid crisis.
HA1c: A statistically significant relationship exists between provider’s post
licensure training and the provider’s belief that the implementation of the 2016 CDC Guideline
will produce improved outcomes in CPM.
RQ2. What is the relationship between the amount of provider’s years’ experience and:
a.

The provider’s knowledge of the 2016 CDC Guideline.
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b.

The provider’s belief that that the 2016 CDC Guideline will reduce the epidemic
opioid crisis.

c.

The provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved outcomes in CPM.
HA2a: A statistically significant relationship exists between provider’s years’

experience and the provider’s knowledge of the 2016 CDC Guideline.
HA2b: A statistically significant relationship exists between provider’s years’
experience and the provider’s belief that that the 2016 CDC Guideline will reduce the epidemic
opioid crisis.
HA2c: A statistically significant relationship exists between provider’s years’
experience and the provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved outcomes in CPM.
RQ3. What is the relationship between the provider’s knowledge of the most current
CDC Guideline and:
a.

The provider’s belief that that the newest CDC Guideline will reduce the
epidemic opioid crisis in relation to CPM.

b.

The provider’s belief that the implementation of the most current CDC Guideline
will produce improved outcomes in CPM.
HA3a: A statistically significant relationship exists between provider’s

knowledge of the most current CDC Guideline and the provider’s belief that that the newest
CDC Guideline will reduce the epidemic opioid crisis in relation to CPM.
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HA3b: A statistically significant relationship exists between provider’s
knowledge of the most current CDC Guideline and the provider’s belief that the implementation
of the most current CDC Guideline will produce improved outcomes in CPM.
RQ4.What is the relationship between the provider’s belief that the CDC Guideline will
reduce the epidemic opioid crisis in relation to CPM and the provider’s belief that the
implementation of the CDC Guideline will produce improved outcomes with regard to CPM?
HA4: A statistically significant relationship exists between belief that the CDC
Guideline will reduce the epidemic opioid crisis in relation to CPM and the provider’s belief that
the implementation of the CDC Guideline will produce improved outcomes about CPM.
RQ5. Do either of following variables act as mediators between the provider’s
knowledge of the 2016 CDC Guideline and the provider’s attitude regarding the implementation
of the 2016 CDC Guideline recommendations in his or her own practice?
a.

The provider’s belief that the 2016 CDC Guideline will reduce the epidemic
opioid crisis in relation to CPM.

b.

The provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved patient outcomes in CPM.

HA5a: The provider’s belief that the 2016 CDC Guideline will reduce the epidemic
opioid crisis in CPM acts as a mediator between the provider’s knowledge of the 2016 CDC
Guideline and the provider’s attitude regarding the implementation of the 2016 CDC Guideline
in his or her own practice.
HA5b: The provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved patient outcomes with CPM acts as a mediator between the provider’s
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knowledge of the 2016 CDC Guideline and the provider’s attitude regarding the implementation
of the 2016 CDC Guideline in his or her own practice.
Methodology
The methodology for this study was quantitative analysis incorporating
exploratory, cross sectional and correlational components. Additionally, the inferential statistics
was utilized, which included multiple regression computation as well as a more comprehensive
structural equation model with path diagram to identify presence of mediating variables.
Results
The respondents surveyed demonstrated varied recall of the 2016 CDC opioid
prescribing guidelines. The study also found knowledge was a statistically significant predictor
of belief variable. However, knowledge alone was not significant predictor of practice.
Belief that the newest CDC Guideline will reduce the epidemic opioid crisis in relation
to CPM was found to be significant predictor practice efforts towards adapting practices to
further impact harm reduction. Individual attitudes were a significant predictor of practice of
harm reduction and practice of utilizing non opioid modalities.
This study results suggest that subjective variable of belief and attitude has a mediating
effect and influence on acceptance and implementation of guidelines and thus exploring
subjective constructs through qualitative methods may further illuminate participant
characteristics, as barriers to guideline adoption.
Significance
The results of the study are integral in understanding healthcare providers' perceptions of
the 2016 CDC opioid prescribing guidelines relating to the betterment of current opioid crisis.
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The study measures practitioners’ knowledge of the guidelines and associated beliefs, attitudes
paradigm and its impact on practice individual clinical practice. Understanding of beliefs and
attitudes of practitioners is significant in practically guiding policy makers to tailor guidelines for
greater adoption and adherence to the intended practitioner.
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CHAPTER II
REVIEW OF LITERATURE
The Clinical Problem-Pain
One of the most common ailments that causes an individual to seek medical attention is
persistent, chronic pain (Gureje et al., 1998). The United States has more 116 million chronicpain patients, exceeding other chronic conditions such as heart disease, cancer, and diabetes
(Dzau & Pizzo, 2014; Institute of Medicine [IOM], 2011; Simon, 2012; Steglitz et al., 2012).
More than 30% of Americans experience some form of chronic pain; among the rapidly aging
population, the presence of chronic pain exceeds 40% of the population (Simon, 2012). The
International Association for the Study of Pain (IASP, 1994) defined pain as an “unpleasant
sensory and emotional experience associated with actual or potential tissue damage” (p. 210).
According to IASP (1994), pain has strong cultural, religious, and psychological components
that alter an individual’s perception and experience. The definition from IASP emphasizes that
pain is chiefly a subjective experience. Pain can be acute, related to cancer, or CNCP (IASP,
1994). Chronic-pain conditions can originate from acute pain, recognized as pain that extends
beyond the period of healing (Simon, 2012). One example is failed back-surgery syndrome,
which reflects on a constellation of symptoms that result in persistent back pain following one or
more spine surgeries (North et al., 1991). CNCP can also present insidiously and transition into a
more prolonged state of unwellness stemming from common conditions such as physical injury,
degenerative musculoskeletal changes of arthritis, fibromyalgia, migraines, shingles, and
neuropathic conditions (Simon, 2012). The last qualifier for CNCP is any pain condition that is
prolonged without relief for a period greater than 3 months (CDC, 2016).
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The debilitating nature of CNCP can be progressively incapacitating when it interferes
with daily functionality, the ability to work, sleep patterns, social activities, family relationships,
and the ability to perform basic common tasks (Brennan, 2015). Additionally, the complexity of
chronic pain also extends into the psychological realm, where 40 to 50% of patients experiencing
chronic pain also experience some degree of anxiety and depressive disorder (Banks & Kerns,
1996). According to the American Pain Society, CNCP is the leading cause of disability and
impacts 16,128 Americans. CNCP has shown to have a devastating effect on a person’s ability to
work, function, and participate in society (Chou et al., 2009).
Gaskin and Richard (2012) analyzed Medical Expenditure Panel Survey (MEPS) data
from 2008 to 2010 and determined that health-related costs due to chronic pain reached as high
as $261–$300 billion annually, with an additional loss of value from lost productivity ranging
from $299 to $335 billion. Based on these data, pain carries a high burden in health care
expenditures, disability compensation, lost productivity, lack of employment, and potential loss
of quality of life. The impact of financial strain on the health care system and human suffering
created an urgency to alleviate this pervasive health problem.
Kirson et al. (2017) studied economic burden on insurers using claims from large
commercially insured data banks containing a population sample of more than 18 million
beneficiaries. The authors compared the cost of treatment for two mutually exclusive groups of
opioid abusers and opioid nonabusers. The health care costs of opioid abusers yielded higher
resource use with an additional $14,810 per patient on an annual basis. However, the increase in
costs for these patients began 5 months prior to a formal diagnosis of opioid abuse, with
treatment for alcohol and other polysubstance abuse that predated the opioid-abuse diagnosis.
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Over the past 20 years, professional organizations and governmental health agencies
supported medical professionals, encouraging the use of opioids as part of their armamentarium
to manage pain conditions (Desbiens et al., 1996; Porter & Jick, 1980). Policymakers and
authoritative agencies championed better treatment and management of undertreated pain
through promotional campaigns such as “Decade of Pain Control and Research” (Brennan et al.,
2016) and pain relief as “a human right” (Baker, 2017, p. 215). The Joint Commission on
Accreditation of Healthcare Organizations (JCAHO) and the American Pain Society (APS)
consensus statement on undertreated pain was the impetus for the development and nationwide
initiative called “Pain as the 5th Vital Sign,” which required use of a patient reported numeric
pain rating scale for all clinical encounters (Berry & Dahl, 2000; Kirsch et al., 2000). This
mandatory objective measure of pain was an expected inquiry, upon every patient encounter.
This may have inadvertently steered practitioners to prescribe an easily accessible
pharmaceutical to relieve the symptom of pain and thereby resolve the pain concern of the
patient.
Societal Problem-Opioids
In response to the demand from the medical community and urgency to treat pain and
suffering, the pharmaceutical industry and market forces increased production of newer
formulations of opioids with higher degrees of potency and extended half-lives (Rowbotham et
al., 2003; Van Zee, 2009). Moreover, prescribers followed in tandem, treating the suffering and
undertreatment of pain with now easily accessible narcotics, thereby decreasing the cost of
unrelieved pain to individuals and society. The realization of decreased pain (despite the choice
of treatment) helped patients feel better and return to more productive life. (Kirson et al., 2017).
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As the production of opioids increased to meet the treatment demand for chronic pain, the
National Vital Statistics System (NVSS) noted that the trajectory of opioid prescriptions for
CNCP treatment had increased dramatically since 2011 (CDC, 2015b; Hedegaard & Miniño
2017; Manchikanti et al., 2012). This increased prescriptive availability of opioids also paralleled
an increase in opioid misuse, with a growing prevalence of abuse, diversion, and mortality
(CDC, 2015a; U.S. Department of Health and Human Services, 2016). Between 2000 and 2014,
opioid-related overdose deaths increased by 137% (Rudd et al., 2016). Nearly 2.1 million people
have misused prescription opioids for the first time (Murphy et al., 2018). According to U.S.
Department of Health and Human Services (2016), 63,600 deaths involved drug overdoses,
which translates to approximately 89 deaths per day (Hedegaard & Miniño, 2017 Seth et al.,
2018). Of those deaths, 66.4% (42,249) were opioid-related and 32,445 were prescription-related
opioid mortalities (Hughes et al., 2016; Seth et al., 2016). Clearly, prescription opioids are
heavily used to treat CNCP.
In 2013, medical personnel dispensed an astonishing 207 million prescriptions in the
United States (Volkow et al., 2014). The 2015 National Survey on Drug Use and Health
discovered that approximately 12.5 million people, age 12 and older, misused prescription pain
relievers (Hughes et al., 2016). The Council of Economic Advisors estimated the economic
burden of the opioid epidemic at $504.0 billion in 2015, reaching 2.8% of the gross domestic
product for that year (Council of Economic Advisors, 2018).
On the regional front, according to the National Institute of Drug Abuse (2016), New
Jersey alone had 1,409 opioid-related overdose deaths, accounting for 16 deaths per 100,000
people. This statistic places New Jersey higher than the national average category, which is 13.3
deaths per 100,000 (National Institute of Drug Abuse, 2016). Furthermore, the Institute
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determined the largest increase in deaths occurred from heroin, with 97 deaths in 2010; heroin
deaths rose to 850 by 2016. In view of this public health crisis, deaths from prescription synthetic
opioids have also risen from 35 to 689 deaths in the same period of 2010 to 2016 (National
Institute of Drug Abuse, 2016). To show the connection between usage and availability,
prescription data from IMS (2016) Health National Prescription Audit revealed that New Jersey
healthcare providers wrote 55 opioid prescriptions per 100 people, accounting for 4.9 million
prescriptions in a single year. Thus, the opioid drug problem has reached a magnitude of crisis
proportions in the United States. The escalation of the negative impact has once again captured
the attention of government agencies, medical organizations, legislators, and the public. Now,
the urgency to curtail this matter has escalated to the highest priority level by all. In particular,
the CDC called this calamity the worst drug-overdose epidemic in U.S. history (Kolodny et al.,
2015).
Naliboff et al. (2011) conducted a 12-month prospective randomized clinical trial to
compare the effectiveness of conservative opioid prescribing strategies with liberal doseescalation strategies on pain relief, functionality, and misuse outcomes. The researchers recruited
a sample of 130 patients exclusively from the pain clinic of the Veterans Affairs Health Care
System of Greater Los Angeles. Accounting for similar variabilities of sex and age among two
groups (94% male with an average age of 52.6 years), the authors showed a significantly greater
rate of increase in the liberal prescribing strategy of opioid-medication dosages compared with
the conservative dose group. Patients in the liberal-dosing strategy experienced an 80% increase
in opioid dosage over the 12 months, whereas the conservative group showed only a 16%
increase in dosage. The liberal group showed a modest benefit in self-reported pain relief with
the liberal-dosing strategy but not in disability functioning. Naliboff et al. concluded the liberal
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escalating-dose group experienced more immediate decreases in pain after taking medication
than those in the conservative group. However, the effect did not last or did not translate into any
group differences in pain scores or greater functioning (Naliboff et al., 2011). One simple
explanation for this phenomenon was the repeated doses needed and tolerance built over time to
a single dosage and a single medication. Tolerance is common problem when prescribing
narcotics but may easily be overlooked by inexperienced practitioner, who is unfamiliar with
pain pathology and nociceptive receptor theory. It is in this regard that practice guidelines are
most relevant.
Practice Guidelines
The American Institute of Medicine (1990) defined clinical-practice guidelines as
“systematically developed statements to assist practitioner and patient decisions about
appropriate health care for specific clinical circumstances” (p. 6). A decade later, the IOM added
that clinical-practice guidelines are statements intended to optimize patient care. Furthermore,
practice guidelines include statements and recommendations resulting from consensus-based
systematic reviews of research evidence, an assessment of the benefits and harms, and alternative
care options, addressing the manner in which patients with a specific condition should be
managed. Moreover, guidelines may identify one or multiple strategies for treatment and are
advisory rather than compulsory suggestions to influence practitioners’ adoption of evidencebased practices in the clinical setting (IOM, 2011). Practice guidelines may be developed by
variety of specialist disciplines from pediatric to geriatric governing bodies. Practice guidelines
can also be developed by varied professional organizations both regionally and locally. Such that
common medical issue may have clinical practice guideline can be developed separately by
physician specialty and, Advance Nurse Practitioner specialty. Multiple clinical guidelines on
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same or similar medical issue may be perplexing to a busy practitioner leading to more
disengagement from adopting suggested guidelines.
CDC Practice Guidelines
The nation's premier health protection agency, CDC, holds public trust with a mission to
save lives and protect people from health threats and epidemics. The agency fulfills its mission,
through conducting research, data collection and disseminating health information that protects
the public against expensive and dangerous health threats, both contagious and noncontagious.
CDC guidelines are developed in response to potential or actual threat to the national public
health. Operating under the U.S. Department of Health and Human Services, the CDC is a highly
influential agency where stakeholders, payers, and policymakers, including medical boards and
prescribers, are often swayed by its influence. In general, CDC Guideline are voluntary and
nonbinding recommendations (CDC, 2016; Dowell et al., 2016). However, practical implications
can affect prescribers treating patients (Baker, 2017). CDC’s recommendations may have farreaching consequences, if adopted into state standards, that require legal compliance.
Additionally, insurer use of the guidelines may create hardships for beneficiaries to obtain
prescribed medications (Zur & Tolbert, 2018).
It has been clearly established that opioid related mortality has become a national threat
to public of epidemic proportion. Medical practitioners prescribing practices and pharmaceutical
availability has contributed, if not compounded this deadly epidemic. In March 2016, the CDC
released the Guidelines for Prescribing Opioids for Chronic Pain. The CDC purposefully crafted
the guidelines to improve the risks and benefits of opioid therapy for CNCP patients by
enhancing the safety and effectiveness of management and decreasing the risks of opioid-use
disorder and opioid-overdose-related deaths (CDC, 2016). The guidelines provide a total of 12
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recommendations. Among the advisory statements are three guiding principles that frame the
recommendations. First, opioid therapy should not be the initial suggested intervention for
CNCP. Nonopioid interventions include physical therapy, cognitive-behavioral therapy, and
nonopioid medications such as acetaminophen or nonsteroidal anti-inflammatory medications.
The second principle aims to reduce the risk of opioid-use disorder and overdose. In this
category, recommendations identify using the lowest effective dosage of opioid > 50 morphine
milligram equivalent per day (MME/day) and titrating with caution to a maximum dosage of 90
MME/day. The third principle addresses prudent prescriber oversight and patient follow up. In
this category, the CDC (2016) encouraged prescribers to incorporate a plan for risk-mitigation
strategies such as avoiding concurrent benzodiazepine prescriptions, prescription drug
monitoring programs, urine drug testing, and methadone referrals.
Practitioners can access many guidelines for opioid-safety prescribing, all with similar
recommendations of using risk-assessment tools; physician–patient-informed signed contracts,
monitoring strategies for aberrant behaviors by urine drug testing, pill counts, and prescriptiondrug monitoring programs (Kahan et al., 2011; Manchikanti, 2012, 2011). Prior to the April 2016
CDC Guidelines, no recommendations placed a ceiling for MME/day on dosages for prescriptive
opioid analgesics (Duensing et al., 2016). The CDC Guideline created a great deal of discourse
among pain advocacy groups and professional organizations regarding potential ramifications
that may result from the severity of the restrictions on the prescribing liberties of practitioners
(McMullen & Howie, 2011).
The influence of the CDC’s has made a direct and swift impact on Veterans Affairs and
the Department of Defense, which have implemented the CDC Guideline into their systemwide
opioid-management strategies (Brennan et al., 2016; Department of Veterans Affairs, 2017;
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Gellad, Good, & Shuklin, 2017). Additionally, individual state legislators have followed suit,
with approximately 28 states passing dosing limits on opioid prescriptions (Blackman, 2018).
Last and most noteworthy, the Centers for Medicare and Medicaid Services (2018) enacted
regulations, effective in 2019, that place a hard audit trigger on beneficiaries who reach
cumulative MME daily doses of 90 MME, as established by CDC Guidelines. Also adopted from
the CDC Guidelines, Medicare Part D will require additional authorizations in the case-review
process for prescriptions exceeding 90 MME (Centers for Medicare and Medicaid Services,
2018).
After an extensive review of literature on the 2016 CDC opioid-prescribing guidelines,
little literature described prescribers’ familiarity and knowledge of the content, or their attitudes
on the benefits of individual patients’ pain management and overall control of the opioid
epidemic., Several themes that arose relating to guideline adherence. There seemed to be vast
educational gaps in provider knowledge. Providers may have been familiar with guidelines but
did not have detailed understanding of the content. Additionally, the providers had conflicting
recall of guidelines specific to organization, state, and association. This can be contributed due to
lack of alignment across authoritative bodies that release guidelines. These influence provider
nonadherence to best-practice guidelines, and cause lack of provider confidence, as well as low
provider satisfaction in managing patients with CNCP. This is a very relevant topic that warrants
further exploration to better understand the knowledge, attitudes, and practices of primary care
practitioners and their intention to accept or reject recommendations in their primary practice
settings. In researching the gap stemming from the lack of literature and information on 2016
CDC Guidelines, enlightening and meaningful results from this study contribute to practices that
may shift opioid-prescribing practices.
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Current Attitudes, Practices opioid prescribing and chronic pain management
Practitioners throughout United States have varied attitudes and approaches to treatment
of chronic pain management and opioid prescribing. Wolfert et al. (2009) studied Wisconsin
physicians’ knowledge, beliefs and attitudes toward opioid analgesic use and discovered that
most physicians believed that it was acceptable medical practice to prescribe opioids for chronic
cancer pain, but only half believed that prescribing opioid should be utilized for non-cancer
patients. The study also revealed approximately, two-thirds of physicians were not concerned
about being investigated for their opioid prescribing practices, but some feared of potential for
investigation that led them to lower the dose prescribed, limit the number of refills for narcotics.
Additionally, among those surveyed 40% of physicians incorrectly thought that both federal and state
laws restricted physicians' prescriptions to only a 30-day supply of narcotics. Furthermore, the study
demonstrated that many physicians who prescribe opioids had a poor knowledge of prescribing
requirements contained in federal and state-controlled substances regulations. While they recognized
presence of guidelines, there was multiple sources of guidelines that practitioners noted but no single
uniformly influential to their individual practice.

Challenges of Prescribers’ Knowledge and Beliefs
Jamison et al. (2014) surveyed primary care practitioners’ beliefs and attitudes of opioid
prescribing and chronic-pain management. The year-long longitudinal study revealed
practitioners had adequate opioid knowledge, but their knowledge of opioids was unrelated to
attitudes on prescribing opioids. The authors studied a sample of 56 practitioners: physicians,
nurse practitioners, and physician assistants from eight centers. Less than half of the practitioners
(46%) worried about addiction but believed they were sufficiently trained in prescribing opioids.
Furthermore 89% expressed concern about opioid misuse and 84% felt that managing CNCP was
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stressful. Jamison et al. found differences in confidence levels between senior practitioners and
junior practitioners. Junior providers expressed greater stress levels and decreased confidence in
managing patients with CNCP and had greater concerns regarding opioid dependence than more
senior providers (p < .05).
Ebbert et al. (2017) investigated associations of attitudes, beliefs, and practice styles
among clinicians prescribing opioids. In a large academic medical center, the authors studied
responses from 720 practicing primary care prescribers—65% physicians and 35% midlevel
practitioners—to assess (a) clinicians’ confidence in managing patients with CNCP, (b) attitudes
regarding opioids as an effective tool for the treatment of CNCP and their satisfaction with
clinical care for CNCP, and (c) consistency in the clinical approach to opioid prescribing. Of the
prescribers, 94% asserted the importance of a consistent approach to opioid prescribing.
However, only 47% of prescribers were confident in their professional ability to care for patients
with CNCP, and 82% expressed reluctance about prescribing opioids for CNCP. The researchers
used the chi-square statistic to test relationships between categorical variables.
Clinicians who were familiar with the CDC (2016) guideline reported higher degrees of
confidence in managing CNCP (74% vs. 61%, 95% CI = 1.09–1.35, chi square = 12.4, p < .01;
Ebbert et al., 2017). Additionally, clinicians reporting familiarity with the CDC guideline were
less likely to believe opioids were effective for CNCP (14% vs. 21%, 95% CI = 0.47–0.95, chi
square = 5.2, p = .02). However, guideline familiarity did not align with provider reluctance to
prescribe opioids to patients with CNCP (81% vs. 83%, RR = 0.98, 95% CI = 0.91–1.05, chi
square = 0.38, p = 0.54). In the same study, Ebbert et al. evaluated practice styles and prescriber
concerns based on familiarity with CDC guidelines. Of 961 participants, 74% disclosed they
follow CDC recommendations, whereas providers who were aware of CDC Guideline were
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twice as likely to report always or frequently screening their patients for depression (49% vs.
24%, RR = 2.05, 95% CI = 1.59–2.64, chi square = 39.1, p < 0.001). Additionally, in line with
CDC recommendations, these providers were also 44% less likely to prescribe concomitant use
of benzodiazepines with opioids (7% vs. 13%, RR = 0.56, 95% CI = 0.35-0.89, chi square = 6.1,
p = 0.01). Lastly, among the 67% of clinicians who were aware of the 2016 CDC Guideline for
CNCP, only 47% sought additional training to increase their knowledge of opioid treatment for
CNCP. Prescribers were more likely to have enrolled in prescription drug-monitoring programs
if they were familiar with a patient who required intervention for opioid abuse or overdose (68%
vs. 51%; 95% CI = 1.14–1.52; chi square =11, p < 0.01; Ebbert et al., 2017).
A Canadian study of 710 family physicians discovered that 40% of practitioners correctly
answered only two of nine opioid-related knowledge questions (Allen et al., 2013). Similarly,
Wolfert et al. (2010) studied 216 Wisconsin-based primary care practitioners and found
multilevel misconceptions about the prescribing of opioids. Additional knowledge deficits
identified among prescribers include inappropriate continuation of opioids and inadequate
monitoring of opioids (Allen et al., 2013).
A small study considered burnout in physicians who care for chronic-pain patients and
revealed more than 60% physicians who treated chronic pain-patients reported emotional
exhaustion (Nathan, 2009). In the same study, about 37.5% reported experiencing high levels of
depersonalization and 19.3% reported a low sense of personal accomplishment. Increased
physician strain can hinder efficient and effective patient care (Nathan, 2009). Strain occurs
when job demands are high and decisional autonomy is low. Additionally, increased physician
strain can block effective patient care. Although workers in many medical disciplines experience
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strain, chronic strain resulting in burnout was highest in disciplines with low levels of personal
control, poor support systems, and high job demands and expectations (Nathan, 2009).
Likewise, in a study of 61 practitioners, primary care prescribers reported low confidence
and dissatisfaction in treating chronic-pain patients (Vijayaraghavan et al., 2012). The authors
found significant gaps in practitioners’ knowledge of effective care to chronic pain patients.
Most providers reported lack of satisfaction in treating CNCP with opioid therapy (Macerollo et
al., 2014). Providers preferred to manage these patients in collaboration with a pain specialist
(Macerollo et al., 2014).
Although guidelines seek to improve patient care by influencing clinical practice,
researchers showed that adoption of information is generally ineffective (Bero et al., 1998). In
systematic review of 109 studies, Bero et al. (1998) concluded that clinical-practice guidelines
have a minimal effect on influencing behavioral change among practitioners. Not surprising,
effective interventions include reminders, multifaceted interventions, and continued educational
meetings. A recent study by McCalmont et al. (2018) investigated familiarity with CDC
Guideline and continuing education with provider characteristics’ influence on compliance with
opioid-prescribing practices. The researchers used a cross-sectional design with 417 prescribers
in rural Oregon. McCalmont et al. concluded that higher hours of continuing education positively
impacted provider confidence in pain management use of CDC guidelines.
While, chronic-pain management and opioid prescribing are well researched in the
literature gaps exist specific to use of prescribing guidelines and best practice. Limited research
exists describing the acceptability and utility of the 2016 release of the CDC guideline. To date,
limited studies evaluated the value and effectiveness of the CDC opioid guideline. Additionally,
research is needed to explore the facilitators and barriers that influence the implementation of
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opioid prescribing guidelines. Lastly, while many studies have examined knowledge, attitudes,
and beliefs regarding chronic pain they have not focused on midlevel practitioners. Given the
increase in midlevel practitioners in the primary care model, it would be prudent to include the
perspectives of nurse practitioners and physician assistants on chronic pain and guideline
implementation.
Gap in the Literature
To date, limited studies evaluated the value and effectiveness of the CDC opioid
guideline. Additional research is needed to explore the facilitators and barriers that influence the
implementation of opioid prescribing guidelines. Lastly, many studies of provider knowledge,
attitude, and beliefs of the management of chronic pain are exclusive of midlevel practitioners.
Given the increase in midlevel practitioners in the primary care model, it would be prudent to
include the perspectives of nurse practitioners and physician assistants on chronic pain and
guideline implementation.
Theory and Conceptual Framework
Despite the dissemination of guidelines by authoritative agencies, successful clinicalguideline implementation, and adherence by medical practitioners to the suggested guidelines
have had variable effect on practitioners’ behavioral changes (Rashidian et al., 2008). Clinical
guidelines are not always easily accepted and implemented by practitioners. There is no singular
theory that explains clinical guidelines adoption and adherence. The multifactorial components
that influence practitioner’s choice of clinical guideline adoption can be explained through the
lens of Diffusion of Innovation Theory by E.M Rodgers.
Diffusion of Innovations theory (DIT, Figure 1) offers a useful theorical support for
guideline adoption. Although utilized in the discipline of business and marketing, DIT provides
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an insight for understanding complexities inherent in the process of adopting novel ideas and
practices (Rogers, 1995). This theory suggests that the adoption of an innovation, in this case
guidelines, involves interaction between (1) the individuals adopting the innovation and (2) the
innovation itself. Rogers (1995) explains the presence of four key factors that influence the rate
of adoption: (1) the adopter's perception of the relative advantage of the innovation; (2) the
compatibility of the innovation with current practices; (3) the perceived degree of difficulty in
the implementation (4) and the visibility of outcomes resulting from adoption of the innovation.

Innovation

communication

Time

Diffusion
Figure 1. Diffusion of Innovation (DIT) Theory, E.M. Rogers 1962.

A second contributing conceptual framework that supports this study is the Knowledge,
Attitude and Practices model. The KAP model proposes that practice is influenced by the two
constructs of attitude and knowledge. The model identifies the knowledge construct through
awareness and familiarity and the attitude construct through agreement, motivation and outcome
expectancy that lead to practice. Knowledge, attitude, and practice studies fundamentally assume
a linear association between knowledge, attitude, and behavioral change (Figure 2).
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Figure 2. The Knowledge-Attitude-Practice Model (Bano et al., 2013)
Conceptual frameworks and theories are critical to understanding behavior patterns
toward compliance with and adherence to guidelines. Fisher et al. (2016) analyzed a qualitative
study built on Cabana’s original framework of knowledge, attitude, and behavior framework,
dividing barriers to guideline implementation into subparts: knowledge (lack of awareness or
familiarity), individual (lack of motivation), and external (guideline and patient related; Cabana
et al., 1999).
Scholars in many disciplines have addressed the issue of clinical-guideline compliance
through various industry lenses. Disciplines that have contributed frameworks to adherence and
compliance frameworks include sociology, psychology, engineering, organizational
management, nursing medicine, and informatics (Gurses et al., 2009). After analysis of the
contributions of various disciplines, Gurses et al. (2009) created a conceptual model to remedy
guideline adherence with focused concentration on the following four major defining
characteristics: clinician characteristics, system characteristics, guideline characteristics, and
implementation characteristics. Cabana et al. (1999) are most recognized for identifying
clinician-related characteristics, which include clinician knowledge due to lack of awareness of
guidelines, clinician attitude related to lack of agreement with the guideline, and skepticism or
lack of outcome expectancy. External barriers were the ambiguity of guidelines and practicality.
Cabana et al. (1999) identified three barriers toward guideline compliance related to
clinicians’ characteristics: clinician knowledge, clinician attitude, and external factors (Figure 3).
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First, the clinician-knowledge components may result from lack of familiarity with or lack of
awareness of the guidelines. Second, clinician attitude may reflect lack of agreement with the
specific guidelines or interpretation of the evidence and applicability to the patient. Lack of
agreement also includes clinician perceptions that the recommended guideline is too restricting
and impractical (Cabana et al., 1999). Additional attitudinal components are skepticism or lack
of outcome expectancy that the suggested recommendation will lead to the desired outcome.
Last, the attitudinal component includes lack of motivation or inertia of formerly cemented
practice routines. The third element is the influence of external variables, where patient
preference presents as a barrier, possibly accompanied by the presence of other environmental
factors such as time constraints, lack of resources, and lack of reimbursements.

Figure 3. Barriers to Physician Adherence to Practice Guidelines in Relation to Behavior Change
(Cabana et al., 1999).
.
Although other models and theories exist, no singular model or framework explains with
absolute clarity the degree of practitioner compliance toward established guidelines. One reason
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may be the complexity of the health care industry and the degree of complexity of clinical
guidelines involving multiple stakeholders and subspecialty disciplines. An example is the 2016
CDC opioid guidelines for CNCP management, directed specifically to primary care
practitioners. However, physicians are only one segment of professionals affected by these
guidelines. Primary care providers also include advanced practice nurses and physician
assistants. Additionally, affected by the 2016 CDC Guideline for CNCP management are
pharmacists, and health care insurers. Therefore, a framework necessary to address the 2016
CDC Guideline on chronic CNCP management ought to be more encompassing and use an
interdisciplinary approach that includes multiple lenses to evaluate factors affecting authoritative
guideline compliance. It is important to highlight that knowledge or attitude, is not necessarily a
strong predictor of behavior alone (Ajzen & Fishbein, 1977). Individualized experiences such as
years in clinical practice or exposure to regional population behaviors adds to practitioner biases
that may influence practice behaviors. Lastly, the addition or lack of continuing education in a
specific area of practice can heavily influence changes in practice behavior. A proposed hybrid
model is presented to support as a foundation of this study (Figure 4).

Figure 4. Conceptual Framework of the Study.
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The pervasiveness of prescription opioids has clearly negatively impacted the health care
industry. To combat the deleterious effects on society and the economy, the CDC (2016) has
moved to disseminate guidelines and recommendations to rein in the opioid epidemic.
Historically, guidelines have not been easily adopted into clinician practices, due to variety of
barriers. To date, limited research studies investigated knowledge, attitude, and practices relating
to the 2016 CDC guidelines. This gap in the literature renders this study relevant and timely.
Using this framework, the study design will answer the following research questions.
Research Questions
1. What is the relationship between the amount of provider’s post licensure training relating to
the area of chronic pain management (CPM) and
a. The provider’s knowledge of the 2016 CDC Guideline.
b. The provider’s belief that that the 2016 CDC Guideline will reduce the epidemic opioid
crisis.
c. The provider’s belief that the implementation of the 2016 CDC Guideline will produce
improved outcomes in CPM.
Research Hypothesis H1a. There is a statistically significant relationship between the amount
of provider’s post licensure training in CPM and the provider’s knowledge of the current
CDC Guideline.
Research Hypothesis H1b: There is a statistically significant relationship between the amount
of provider’s post licensure training relating to area f CPM and the provider’s belief that
that the current CDC Guideline will reduce the epidemic opioid crisis in relation to CPM.
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Research Hypothesis H1c: There is a statistically significant relationship between the amount
of provider’s post licensure training in CPM and the provider’s belief that the
implementation of the current CDC Guideline will produce improved outcomes in CPM.
2. What is the relationship between the amount of provider’s years’ experience and
a. The provider’s knowledge of the 2016 CDC Guideline.
b. The provider’s belief that that the 2016 CDC Guideline will reduce the epidemic
opioid crisis.
c. The provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved outcomes in CPM.
Research Hypothesis H2a: There is a statistically significant relationship between the amount
of providers’ years’ experience and provider’s knowledge of the current CDC Guideline.
Research Hypothesis H2b: There is a statistically significant relationship between the amount
of provider’s years’ experience and the provider’s individual attitude that the current
CDC Guideline will reduce the epidemic opioid crisis in relation to CPM.
Research Hypothesis H2c: There is a statistically significant relationship between the amount
of provider’s years’ experience and the provider’s belief that the implementation of the
current CDC Guideline will produce improved outcomes about CPM.
3. What is the relationship between the provider’s knowledge of the most current CDC Guideline
and
a. The provider’s belief that that the newest CDC Guideline will reduce the
epidemic opioid crisis in relation to CPM.
b. The provider’s belief that the implementation of the most current CDC Guideline
will produce improved outcomes in CPM.
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Research Hypothesis H3a: There is a statistically significant relationship between the provider’s
knowledge of the newest CDC Guideline and the provider’s belief that that the CDC
Guideline will reduce the epidemic opioid crisis in relation to CPM.
Research Hypothesis H3b: There is a statistically significant relationship between the provider’s
knowledge of the CDC Guideline and the provider’s belief that the implementation of the
current CDC Guideline will produce improved outcomes in CPM.
4. What is the relationship between the provider’s belief that the CDC Guideline will reduce the
epidemic opioid crisis in relation to CPM and the provider’s belief that the implementation of
the CDC Guideline will produce improved outcomes with regard to CPM?
Research Hypothesis H4: There is a statistically significant relationship between the
provider’s belief that the CDC Guideline will reduce the epidemic opioid crisis in
relation to CPM and the provider’s belief that the implementation of the CDC
Guideline will produce improved outcomes with regard to CPM.
5. Do either of following variables act as mediators between the provider’s knowledge of the
2016 CDC Guideline and the provider’s attitude regarding the implementation of the 2016
CDC Guideline recommendations in his or her own practice?
a. The provider’s belief that the 2016 CDC Guideline will reduce the epidemic
opioid crisis in relation to CPM
b. The provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved patient outcomes in CPM.
Research Hypothesis H5a: The provider’s belief that the 2016 CDC Guideline will reduce
the epidemic opioid crisis in relation to CPM acts as a mediator between the
provider’s knowledge of the 2016 CDC Guideline and the provider’s attitude
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regarding the implementation of the 2016 CDC Guideline recommendations in his or
her own practice.
Research Hypothesis H3a: The provider’s belief that the implementation of the 2016 CDC
Guideline will produce improved patient outcomes with regard to CPM acts as a
mediator between the provider’s knowledge of the 2016 CDC Guideline and the
provider’s attitude regarding the implementation of the 2016 CDC Guideline
recommendations in his or her own practice
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CHAPTER III
METHODOLOGY
A thorough consideration was given to utilizing an appropriate methodology to meet the
aims of the study. Among the methods considered were qualitative methods, quantitative
methods, and a mixed methodology. Quantitative methods best matched the aims of the study.
The reasons for the quantitative methods are primarily directed from McCalmont’s research
study utilizing the study tool, as this study replicates with established measurement of Likert
scales. The quantitative methodology is less biased and objective measure to quantify behaviors,
opinions, attitudes, and generalize from a larger population. Furthermore, the quantitative data is
precise, reliable, and consistent, and repeatable. Among the factors to be considered in the
quantitative study were an appropriate research design, developing a survey instrument that
would allow for collection of sufficient data to calculate the study variables needed to answer the
research questions, deciding which statistical tests would be most appropriate, and determining a
target sample size that would produce sufficient power for the statistical analyses. The PI
considered the best option to obtain a representative sample of participants to test the research
hypotheses for the desired targeted population, given the time and resource constraints applicable
to practicing providers who constituted the sample. Once these decisions were made, the PI
directed the focus toward how to best conduct the study to ensure participants met eligibility
requirements the surveys were administered with integrity and confidentially, and the data
accrued from the surveys were complete and free of errors.
Research-Study Design
The design for this quantitative non-experimental cross-sectional design. The intentional
choice to use a cross-sectional design rests with the advantage that it captures participant data at
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a single point in time rather than at several consecutive times, as in longitudinal studies (Field,
2018). Another advantage to a cross-sectional study design is that it eliminates the chance that
history or testing effects will distort influence on participants’ scores, as could happen with a
longitudinal design (Portney & Watkins, 2009). The advantage to longitudinal studies is the
ability to show patterns of a variable over time. However, longitudinal designs are time intensive
as well as costly. Additionally, there is greater risk for participant attrition and require larger
population samples. This study was cross-sectional because each medical provider participating
in the study completed the survey instrument in a single sitting and only once. The entire datacollection phase of this study took place in a relatively short period of time (3 months), further
minimizing the potential influence that the passage of time might have had on study results. The
benefit of a cross-sectional study over longitudinal study design is that it allows researchers to
compare many different variables at the same time.
The nature of this study was correlational. Correlational studies explore the relationships
among two of more variables captured by the study (Portney & Watkins, 2009). This study
clearly fits this definition, as the first three research questions aimed to measure the degree of
associations among the following variables: providers’ amount of post licensure training during
the past 3 years in CNCP management; the provider’s knowledge of the contents of the 2016
CDC guidelines; the providers’ belief that the 2016 CDC Guideline would reduce the epidemic
opioid crisis in relation to chronic-pain management; and their belief that the implementation of
the current CDC Guideline would improve patient outcomes in chronic-pain management. A
fifth research question addresses variable relationships, asking whether either of the two belief
variables mentioned in the previous sentence acted as a mediator on the relationship between a
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provider’s knowledge of the 2016 CDC guideline and their attitude toward implementing the
recommendations in this guideline to their own practice.
Sampling Procedure and Survey Implementation
The target population for this study was physicians, physician assistants, and nurse
practitioners located throughout the United States who treat and manage patients experiencing
CNCP, who are aware of the 2016 CDC guidelines, and who hold prescriptive privileges
including Schedule III medications, such as opioids. Exclusion criterion included physicians who
had specialty training, physicians and practitioners in training and practitioners who responded
as not having awareness of the 2016 opioid prescribing CDC guidelines. The rationale for the
exclusion criteria for specialty trained physicians related directly to the guidelines intention of
addressing generalist practitioners and not specialty practitioners. The second group that was
excluded from the study of learner practitioners was due to lack of ability for decision making
and prescriptive authority of narcotics. Lastly, providers who were unaware of the guidelines
were excluded due to applicability of knowledge component of the guidelines would lead to
skewed results.
The survey instrument was electronically disseminated through three national
professional associations: the American Association of Nurse Practitioners, the American
Association of Physician Assistants, and the Academy of Family Practice Physicians. These
organizations made the survey tool available to their members for a specified window of time (3
months), either on their respective websites or by email invitation containing a link to the survey.
The rationale behind this approach was to make the survey tool accessible to physicians,
physician assistants, and nurse practitioners located throughout the United States. The
professional associations tend to have a wide range of members with varying experience and
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training in their respective fields. The goal was for the study to yield a nationally representative
sample of Family practice physicians, physician assistants, and nurse practitioners who had
various levels of post licensure training (ranging from none to many hours) in the area CNCP
management. Prior to initiating and deploying the survey tool, the PI submitted and obtained
approval for this study from the Seton Hall University Institutional Review Board (SHU-IRB;
(see Appendix A).
Determination of Target Sample Size
Prior to commencing the data-collection phase of the study, the PI had to obtain an idea
of the range of sample sizes needed for the analyses to produce sufficient levels of statistical
power. The standard of sufficient statistical power employed for this purpose was 1 -  = .80. To
obtain these recommended sample sizes, a G*Power tool was run on an a priori basis, assuming
an α level of 0.05 with small, medium, or large effect sizes (See Appendix B). As the PI used
correlational tests Pearson’s r, to evaluate the first six research hypotheses, the statistic used to
measure effect size for each test was the absolute value of the respective correlation coefficient
(i.e., |r| for Pearson, with values of 0.10, 0.30, and 0.50 used to represent small, medium, and
large effect sizes, respectively (Cohen, 1988).
The PI also ran a priori G*Power analyses for the final research hypotheses, which
involved mediational path analyses. Because the required sample sizes for the correlational
components of these path analyses were already obtained from the G*Power performed for the
first six research hypotheses, what remained was running the G*Power for the multiple
regression components of the path analyses. These latter G*Power analyses assumed an α level
of .05 and two predictor variables (i.e., the knowledge variable and the appropriate belief
variable) along with small, medium, or large effect sizes. Based on the standards promulgated by
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Cohen (1988) for regression models, the small, medium, and large effect sizes corresponded with
the coefficient of determination (R2) values of 0.01, 0.06, and 0.14, respectively. The
recommended sample sizes produced by these various a priori G*Power analyses (Table 1).

Table 1.
Recommended Sample Sizes

Research hypotheses

Small effect size (n)

Medium effect size (n)

Large effect size (n)

1a, 1b, 1c, 2a, 2b, 3

616

67

23

4a and 4b

957

143

63

The PI focused on the recommended sample sizes for Research Hypotheses 4a and 4b, as
they were greater than the corresponding recommended sample sizes for the other six
hypotheses. A minimum sample size of n = 957 would be required for sufficient power of 1 -  =
0.80 if either of the multiple regressions run for Research Hypotheses 4a or 4b produced a small
effect size that was statistically significant. In practice, however, it is more common for
statistically significant results to have effect sizes in the medium to large range. Therefore,
initially the researcher planned to obtain at least n = 143 eligible participants to complete the
survey instrument for the study.
The survey tool contained eligibility questions designed to eliminate potential
participants who were not part of the targeted population of the study, as well as safeguards
designed to ensure that all items in the survey were answered properly before the survey could be
submitted, the PI was not concerned that any of the survey data was received would have to be
discarded due to ineligible participants, input errors, or incompleteness. The researcher planned
to run G*Power on a post hoc basis after performing each statistical test to determine the attained
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statistical power level for that test. If any of these power levels fell short of the 1 -  = 0.80
standard, the researcher had planned to recruit additional participants and rerun the statistical
analyses with these additional surveys such that the increased sample size would produce
sufficient power.
Survey Instrumentation
The PI used an existing survey tool published in Journal of Opioid Management in
original research by McCalmont et al., (2018). Lead author permission was obtained through
electronic communication. The questionnaire did not fall under copywrite restriction; thus,
request for copyright permission was obviated. The study included III sections. Section I was
dedicated to demographics inquiries of age, profession, years in practice, ethnicity/race, practice
type and practice region. Section II inquiry related to awareness of 2016 CDC guidelines.
Section III Likert scaled statements relating to beliefs and attitudes of 2016 CDC opioid
prescribing guidelines. The PI built upon this study by incorporating a section on factual recall of
2016 CDC opioid guideline recommendation, form of multiple-choice questions. This section
was discussed at length with guidelines authorship team for accurate representation of CDC
guidelines. The study was disseminated in an electronic format (see Appendix C), utilizing
Survey Monkey platform. The decision to develop a computer-based survey tool was to allow for
a wide dissemination of the survey to the targeted audience through the internet; to eliminate the
need to secure physical locations, printed materials, and personnel to administer the survey to
participants; and to reduce the incidence of ineligible or incomplete surveys, as the survey
instrument itself contained safeguards to flag or prevent these problems. A computerized survey
format also permitted the PI to download the survey data collected from the group of participants
directly into an electronic medium (a Microsoft Excel® spreadsheet) for further compilation.
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The PI designed the electronic survey-dissemination process to protect the confidentiality
of participants, as email addresses were not accessible to the researcher. Further, the anonymity
of participants were ensured due to the absence of any personal identifiers on the survey
instrument, such as name, physical address, telephone number, names of any employers or
schools attended, social security number, or Drug Enforcement Administration registration
number. The initial disclosure statement in the solicitation letter sent with the survey tool clearly
stated the voluntary nature of the survey and its low risk to the participants. The survey
instrument consisted of the following five sections.
Demographics
Demographics of the survey included questions designed to obtain descriptive
information about the medical-provider participant such as age, level of education, profession
(physician, physician assistant, nurse practitioner), years of experience as a medical provider, the
state where the provider currently practices, and the provider’s number of post licensure
continuing medical education hours (CME) over the past 3 years in CNCP management. In
addition, this section contained two eligibility questions: whether the participant was aware of
the 2016 CDC guideline and whether the participant had a Drug Enforcement Administration
registration number. Negative responses to either of these questions disqualified the participant
from the study because the focus of the study was only on those providers who had awareness of
the existence of the CDC guideline for prescribing opiates and those who were legally permitted
to prescribe opiates.
The items in this section used to answer the research questions were the providers’ CME
hours over the past 3 years in CNCP management and providers’ years of experience. Relating to
the CME inquiry, participants selected from a drop-down menu denoting one of six ranges for
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this variable: 0 (i.e., no training); 1–4 hours; 5–9 hours; 10–19 hours; 20–29 hours; and 30 hours
or more. The rationale for using ranges to report this variable was related, in part, to the
realization that the provider participant may not have been able to recall their exact number of
hours of CNCP management training during the past 3 years but could select the appropriate
range in which these earned hours of CME for pain management fell. The researcher also
thought it important to include a “0 (no training)” category to distinguish those participants who
had no recent CME in pain management. In developing this set of ranges, A concerted effort was
made to include enough ranges to differentiate participants with only a little post licensure
training in pain management from those who had moderate and significant amounts of CME
training in this area. An additional relevant factor was that states’ requirements regarding the
amounts of continuing education medical providers must receive in their areas of practice varied
from very lax to significant.
Knowledge of the 2016 CDC Guideline
This section consisted of specific objective questions regarding the contents of the most
current CDC opioid prescribing guideline. Each of the 12 questions in this section was multiple
choice in nature with four potential answer choices (labeled A, B, C, and D) for each question.
Participants’ composite scores in this section were the number of these questions answered
correctly. The questions drew directly from the CDC website on the self-evaluation tool for
opioid prescribing guidelines, with permission. https://www.medscape.org/viewarticle/881589.
https://emergency.cdc.gov/coca/calls/2018/callinfo_031318.asp.; Additionally, the researcher

contacted the guideline authors who provided input on the final version used in this study.
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Study Variables
To answer the research questions, the researcher compiled the following items from the
survey instrument for each study participant: The variables evaluated in this study were four
predictor variables and two outcome variables. Since, this study was not experimental design
study, the need for control variables were obviated.
Predictor or Independent Variables:
1. The number of hours of post licensure training over the past 3 years in CNCP
management.
2. The number of years in practice.
3. The composite score on knowledge of the 2016 CDC guideline (Knowledge).
4. The composite score on the belief that the 2016 CDC guideline would reduce the
epidemic opioid crisis in relation to chronic-pain management (Belief).
Outcome or Dependent Variables:
1. The composite score on the attitude that the 2016 CDC guideline would produce
improved outcomes in chronic-pain management (Individual Attitude).
2. The composite score on the participant’s attitude regarding the implementation of
the 2016 CDC guideline recommendations concerning reducing the chronic
epidemic opioid crisis in their own practice (Practice 1 and 2).
The number of hours of post licensure training, is an ordinal variable because the six
possible choices for the range in which the participant’s hours of post licensure CNCP training
over the past 3 years has a natural order. In contrast, the composite score on the knowledge of the
CDC guideline is a ratio-level variable because this score is a true number (hence, differences
between any two scores are meaningful) with a natural zero point (Field 2018).
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Each of the latter four items on the list shown above are sums of Likert-style scores that
are ordinal-level variables. Although some statisticians believe that a sum of Likert scores
produces a composite variable that is ordinal (but not interval) in nature and hence to which
researchers can only apply nonparametric statistical tests, other researchers have gained
consensus and are comfortable applying parametric methods to these types of composite
variables under certain conditions (Sullivan & Artino, 2013). These criteria include the
following: using a minimum 5-point Likert-type scale for each individual survey item
contributing to the composite variable, including at least five individual Likert-type scores to
obtain the composite variable, and testing to see whether the composite variable is normally
distributed (Grace-Martin, 2012). Sullivan and Artino also suggested a minimum sample size of
at least five participants when performing statistical tests with this type of composite variable.
Table 1 summarizes the assigned name, description, measurement level, method of calculation,
and possible score range of each of these six variables.
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Table 2
Summary of Attributes of Variables Used in Analysis

Measurement
level
Method of calculation

Description

Possible score
range

(CME)_HRS

Number of hours of post licensure
Ordinal
training during past 3 years in CNCP
management

Select appropriate
range from 6 possible
choices

KNOWLEDGE

Composite score on knowledge of
2016 CDC guideline

Ratio

Number of correctly 0–12
answered questions on
a 12-item objective
multiple-choice test

OPIOID_BELIEF

Composite score on belief that 2016
CDC guideline will reduce chronic
opioid crisis in relation to CNCP
management

Ordinal

Sum of scores on 6 9- 6–30
point Likert-type scale
items

ATTITUDE

Composite score on attitude that 2016 Ordinal
CDC guideline will produce improved
patient outcomes in CNCP
management

Sum of scores on 10
9-point Likert-type
scale items

Choices range
from “0 (i.e.,
no training)”
to “30 hours or
more”

10–50

PRACTICE I
Composite score on the participant’s Ordinal
(REDUCE HARM) attitude regarding implementation of
the 2016 CDC guideline
recommendations concerning
reducing the chronic opioid crisis in
their own practice

Sum of scores on 6 9- 6–30
point Likert-type scale
items

PRACTICE 2
(Increase
Modalities)

Sum of scores on 10
9-point Likert-type
scale items

Composite score on the participant’s Ordinal
attitude regarding implementation of
the 2016 CDC guideline
recommendations concerning
improved patient outcomes in their
own practice

10–50

Note. CME = continuing medical education, CNCP = chronic non-cancer pain, CDC = Centers
for Disease Control and Prevention.
Belief That the 2016 CDC Guideline Would Reduce the Opioid Epidemic Crisis
This section consisted of six statements about the provider’s perception regarding the
effectiveness of the CDC Guideline in reducing the epidemic opioid crisis in relation to chronicpain management. Responses to each of these statements was on a 9point Likert-type scale (with

41

responses ranging from 1 = Strongly Agree to 9 = Strongly disagree). All statements in this
section were positively worded; hence no reverse scoring was necessary.
The researcher adapted the statements from a survey instrument (specifically, Item 5 of
that survey) used in the study by McCalmont et al. (2018), with written permission, which
investigated the impact of the 2016 CDC Guideline on Oregon medical providers. The researcher
obtained a composite score by summing individual Likert scores for the 10 items appearing in
the section. The PI eliminated one statement appearing in the original McCalmont et al. survey
because the statement was specific to the Oregon Health Plan, thus not relevant to the current
study. The alpha, as found in the results chapter, demonstrate that this removal did not impact the
reliability of the scale.
Attitude Regarding the Implementation of the 2016 CDC Guideline Recommendations in
the Provider’s Own Practice
This section contained 16 statements about a provider’s attitude regarding the
implementation of the recommendations promulgated by the 2016 CDC guideline in their own
practice. The responses to each of these statements was on a 9-point Likert-style scale (with
responses ranging from 1 = Strongly Agree to 9 = Strongly disagree). The researcher grouped
these statements into two parts: A and B. Part A consisted of six statements, each addressing the
CDC recommendations regarding reducing the chronic opioid crisis, whereas the ten statements
in Part B focused on CDC recommendations for improving CNCP patient outcomes. The PI
obtained statements appearing in Part A by rewording statements from the third section of the
survey (which addressed the belief that the CDC guideline would reduce the chronic opioid
crisis), so they apply to the particular practitioner and their patients rather than to the medical
profession as a whole. In a similar fashion, for Part B, the PI followed the same steps regarding
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the statements comprising the fourth section of the survey (focused on the CDC guideline’s
impact on producing better patient outcomes), so they, too, would specifically address the
attitudes of the medical provider in relation to their own practice.
Prior to developing this section of the survey instrument, the PI reviewed the method
employed by Kernodle (1998) to derive an attitudinal variable from their survey data for use in
their study, which also addressed the adaptation of sets of practice guidelines by medical
providers. Kernodle’s method built on Fishbein’s and Ajzen’s (1975) definition of attitude,
which states that a combination of an individual’s behavioral beliefs and their appraisal of the
relevant outcomes associated with those beliefs, determines a person’s attitude. To calculate the
value of their attitudinal variable, Kernodle took the product between the Likert-type score for
each item in the behavioral-beliefs section of the survey and the Likert-type score for the
corresponding item (i.e., the outcome evaluation for that behavioral belief) in the attitudinal
section of the survey and summed the products.
Because Research Question 5 of this study investigates whether each of the two belief
variables (derived in Sections III and IV of the survey instrument) acts as a mediator between the
knowledge variable and the appropriate attitudinal variable (from either Part A or Part B of
Section V of the survey), it is important that the belief variable and the corresponding attitudinal
variable share no common elements in their derivations. Sharing common elements would result
in a built-in correlation between these two variables, which would distort the outcome of the
mediation path analysis. For this reason, the researcher did not apply the method described in the
Kernodle (1998) study to derive composite scores for the attitudinal variables used in this study.
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Validity and Reliability of the Survey Instrument
The researcher addressed the validity and reliability of the various sections (other than
the demographics section) of the survey instrument prior to collecting the data. In constructing
the multiple-choice questions on knowledge of the 2016 CDC guideline section, the PI created
questions that covered the content of all 12 recommendations detailed in the 2016 CDC
document itself. Additionally, then researcher believed this knowledge section would be highly
reliable because the Cronbach’s alpha for this section of the survey tool in the McCalmont et al.
(2018) study, which also addressed participants’ familiarity with the 2016 CDC Guideline (i.e.,
Item 8 of that survey), was α = .90. Further, the authors of the original 2016 CDC opioid
prescribing content guidelines evaluated the knowledge section for face validity. The authors of
the guideline writing team reviewed the knowledge content at three separate time periods. The
researcher eliminated three questions due to concerns of ambiguity of answer choices, after
consultation with guideline authors. Reliability was tested using Cronbach alpha, as seen in
Chapter 4.
Because the authors of the McCalmont et al. (2018) study did not discuss the issue of
validity in relation to the sections of their survey (i.e., Items 5 and 17), which I adapted for use in
the two belief sections of this study’s survey instrument, the PI relied on the method used by
Kernodle (1998), in which the author solicited a group of experts in the field of behavioral
characteristics related to guideline use and asked them to evaluate the validity of these sections
of the survey. For reliability, the Kernodle study reported that the Cronbach’s alphas for the
attitudinal sections of the survey tools designed to measure guideline compliance for four
different medical practices ranged from α = 0.88 to α = 0.96. Despite some differences between
the ways Kernodle calculated the composite value of the attitudinal variable and this study, the
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researcher was confident that this section of my survey would also exhibit a high degree of
internal consistency. Additionally, after deploying the survey instrument, the researcher
conducted factor analysis on each of the sections discussed for validity appropriateness of
constructs.
Once the study data accrued, the researcher evaluated the reliability of the knowledge
section of the survey, along with the reliabilities of the two belief sections and Parts A and B of
the attitudinal section by calculating separate Cronbach’s alphas for each of these sections and
parts. The PI recognized, however, that Cronbach’s alpha is not an appropriate tool to evaluate
count variables (Cronbach, 1980). Considering this limitation, the researcher performed a
principal-axis factor analysis on each section to determine the main constructs (i.e., factors)
underlying the items in that survey section. This generated a matrix displayed for each survey
item corresponding to the factor loadings of the main constructs. An examination of the
magnitudes of these factor loadings allowed me to determine which of these constructs had the
greatest influence on each item. Using this, scales were created. As a final step, the PI calculated
separate Cronbach’s alphas for the scales shown in the factor analysis. Because the overall alpha
value for a given survey section is an inappropriate measure of internal consistency when that
scale has several underlying constructs (Field, 2018), this latter set of alphas by subscale
provided a more accurate assessment of that section’s reliability (Cronbach, 1951).
Data Compilation
At the conclusion of the data-collection period, the researcher compiled and downloaded
the information from the completed surveys into a Microsoft Excel spreadsheet. A single master
spreadsheet was organized, each row contained the survey data for a particular participant, and
each column contained responses across all participants on a data item in the survey. The top row
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of the spreadsheet contained the SurveyMonkey-generated names for each survey item. To
prepare this data file so it could be used for statistical analyses, the researcher carried out the
following manipulations:
 After reviewing the SurveyMonkey-generated names for each data item, the PI
created and entered more descriptive names that adhered to SPSS-variable naming
rules for these items.
 For the number of CMEs, the PI created a new variable using Excel formulas,
assigning a number to each of the six possible categorical selections for this item.
These assignments were as follows: 1 for “0 (no such training)”; 2 for “1–4 hours”; 3
for “5–9 hours”; 4 for “10–19 hours”; 5 for “20–29 hours”; and 6 for “30 hours or
more.”
 The researcher calculated the composite score on the knowledge of the 2016 CDC
guideline, and the composite Likert-style scores for the reduction in the epidemicopioid-crisis belief variable, the improved-patient-outcomes belief variable, and the
two practice attitudinal variables.
 Last, for some of the nominal-level demographic variables (such as level of
education, profession, state of practice, and type of practice), the researcher assigned
a variable with a numerical code to each possible category of that variable. The PI
created a new variable for the profession item, where an assignment of number 1 for a
physician, 2 for a physician assistant, and a 3 for a nurse practitioner.
Safeguards were created in the survey instrument to prevent the completion of the survey
by an ineligible potential participant and to ensure participants completed all items before
submitting the survey. Hence, there was no reason to clean the data by eliminating ineligible or
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incomplete surveys. Once these steps were complete, the data was uploaded to IBM SPSS to
perform the statistical analyses.
Descriptive and Inferential Statistical Analyses
After collecting, compiling, and uploading survey data to SPSS, the PI ran various
descriptive and inferential statistical analyses on the data.
Descriptive Analyses
The descriptive analyses involved producing several tabular and graphical exhibits to
obtain a better understanding of the characteristics of the medical providers included in the
sample. Several exhibits provided information on the demographics of the sample such as age,
level of education, profession (physician, physician assistant, or nurse practitioner), years of
experience, geographic state of practice, type of practice, and the number of hours of CME
training during the past 3 years in CNCP management. Additionally, the researcher produced
tables and graphs summarizing participants’ responses for the remaining sections of the survey
tool. These tables and graphs included exhibits summarizing key sample metrics (such as the
mean, median, and standard deviation) for the composite scores calculated for each of these
variables.
Inferential Analyses
Appropriate Inferential statistical tests were performed to test research hypotheses
corresponding to each of the subparts of the five research questions. A summary of the
inferential statistical tests chosen to evaluate each of the research hypotheses is detailed below.
Each summary lists the study variables applicable to the given research hypothesis, the name(s)
of the statistical test(s) conducted to evaluate that hypothesis, and a brief discussion of why the
selected tests were appropriate.
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Research Hypothesis 1a
Variable 1. Number of hours of CME training during the past 3 years in CNCP
management (CME_HRS)—Ordinal level
Variable 2. Composite score on the knowledge of the 2016 CDC guideline
(Knowledge)—Ratio level
Research Hypothesis 1a states that a statistically significant relationship exists between
the two variables listed above. The statistical test applied was Pearson’s correlation r.
Researchers use Pearson’s correlation to find a linear relationship between two variables (Field,
2018).
Research Hypothesis 1b
Variable 1. Number of hours of CME training during the past 3 years in CNCP
management (CME_HRS)—Ordinal level
Variable 2. Composite score on the providers’ belief that the 2016 CDC guideline would
reduce the epidemic opioid crisis in relation to CNCP management (BELIEF)—Ordinal level
Research Hypothesis 1b states that a statistically significant relationship exists between
the two variables listed above. The statistical test applied was Pearson’s correlation r.
Researchers use Pearson’s correlation to find a linear relationship between two variables.
Research Hypothesis 1c
Variable 1. Number of hours of CME during the past 3 years in CNCP management
(CME_HRS)—Ordinal level
Variable 2. Composite score on the providers’ belief that the implementation of the 2016
CDC guideline would produce improved patient outcomes with regard to CNCP management
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(BELIEF)—Ordinal level. The statistical test applied was Pearson’s correlation r. Researchers
use Pearson’s correlation to find a linear relationship between two variables.
Research Hypothesis 1c states that a statistically significant relationship exists between
the two variables listed above. The statistical test applied was Pearson’s correlation r. Pearson’s
correlation is used to find a linear relationship between two variables.
Research Hypothesis 2a
Variable 1. Composite score on the knowledge of the 2016 CDC guideline
(KNOWLEDGE)—Ratio level
Variable 2. Composite score on the belief that the 2016 CDC guideline would reduce the
epidemic opioid crisis in relation to CNCP management (BELIEF)—Ordinal level
Research Hypothesis 2a states that a statistically significant relationship exists between
the two variables listed above. Because the _BELIEF variable is a sum of Likert-type scale
variables, Sullivan and Artino (2013) and Grace-Martin (2012) suggested that if certain
conditions are satisfied, this composite-score variable can be treated as an interval-level variable
when running statistical tests, allowing the use of a parametric test. These conditions follow: a
minimum of a 5-point Likert-type scale for each item included in the composite score, at least
five individual Likert-type scale items comprising the composite score, a sample size of at least n
= 5, and a distribution of the composite score variable that is approximately normal. The PI
selected the Pearson’s r correlation as the parametric test for this research hypothesis because it
is appropriate for measuring an association when both variables are either interval level or ratio
level. The researcher ran the Pearson’s r correlation test on a two tailed basis to be consistent
with the wording of the research hypothesis.
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Research Hypothesis 2b
Variable 1. Composite score on the knowledge of the 2016 CDC Guideline
(KNOWLEDGE)—Ratio level
Variable 2. Composite score on the belief that the 2016 CDC Guideline would produce
improved patient outcomes with regard to CNCP management (OUTCOME_BELIEF)—Ordinal
level
Research Hypothesis 2b states that a positive relationship exists between the two
variables listed above. The researcher selected Pearson’s r correlation as the parametric test for
this research hypothesis because it is appropriate for measuring an association when both
variables are either interval level or ratio level. The researcher ran the Pearson’s r correlation test
on a right-tailed basis to be consistent with the wording of the research hypothesis.

Research Hypothesis 3
Variable 1. Composite score on the belief that the 2016 CDC guideline would reduce the
epidemic opioid crisis in relation to CNCP management (Opioid Belief)—Ordinal level
Variable 2. Composite score on the belief that the 2016 CDC Guideline would produce
improved patient outcomes regarding CNCP management (BELIEF)—Ordinal level
The PI selected the Pearson’s r correlation as the parametric test for this research
hypothesis because it is appropriate for measuring an association when both variables are either
interval level or ratio level. I ran the Pearson’s r correlation test on a right-tailed basis to be
consistent with the wording of the research hypothesis.
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Research Hypothesis 4a
Independent variable. Composite score on the knowledge of the 2016 CDC guideline
(Knowledge, CME training, Belief Scale, Individual Attitude Scale).
Dependent variable. Composite score on the participant’s attitude toward implementing
the CDC guideline recommendations concerning reducing the chronic opioid crisis in their own
practice (Practice Scale I –Harm Reduction); (Practice Scale II-Non-Opioid Modalities)
Intervening variable. Composite score on the belief that the 2016 CDC guideline would
reduce the epidemic opioid crisis in relation to CNCP management (Opioid Belief)—Ordinal
level
Statistical tests. Mediation path analysis—Parametric
To determine whether the intervening variable was acting as a mediator between the
independent and dependent variables, the PI proposed a path analysis. Figure 5 presents a
schematic diagram of this path analysis. The significance of utilizing this method is to help
explain more clearly hypothesized patterns of directional and nondirectional relationships among
a set of observed (measured) and unobserved (latent) variables (MacCallum & Austin, 2000).
The purpose of the model, in the most common form of SEM, is to account for variation and
covariation of the measured variables (MVs). With that in mind, a path diagram or a pictorial
presentation was constructed as shown below to test relationships between dependent variables
and multiple independent variables. Path analysis is useful because, unlike other techniques, it
provides a focused view of relationships among all the independent variables. This results in a
model showing directional mechanisms through which independent variables produce both direct
and indirect effects on a dependent variable. A measured variable (MV) is a variable that is
directly measured whereas a latent variable (LV) is a construct that is not directly measured.
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Direct effect is a directional relation between two variables, e.g., independent, and dependent
variables Indirect effect is the effect of an independent variable on a dependent variable through
one or more intervening or mediating variables. While there are various programs that can be
used in this analysis, the researcher chose to utilize SPSS supported AMOS software for the
analysis.
Figure 5 presents a schematic diagram of this path analysis.

Figure 5. Path Analysis for Research Hypothesis 4a

In Figure 5 represents the various paths that are included in the structural equation model.
The a represents the path between the knowledge and individual attitude scale variables, whereas
b represents the relationship between the opioid belief and both practice variables. Path c is the
relationships between the knowledge and practice variables. Assuming a, b, and c are all
statistically significant, the opioid belief variable can be considered a mediator between the
knowledge and the two practice variables. To determine whether opioid belief is a mediator
between the knowledge and the two practice variables, one must show that the inclusion of the
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opioid belief variable as a predictor in the multiple regression model causes the significant
relationship between the knowledge and opioid attitude variables to become either nonsignificant
or to have a large reduction in magnitude (Baron & Kenny, 1986).
Research Hypothesis 4b

Independent variable. Composite score on the knowledge of the 2016 CDC guideline
(Knowledge)—Ratio level
Dependent variable. Composite score on the participant’s attitude toward implementing
the CDC guideline recommendations concerning improved patient outcomes in their
practice (Attitude)—Ordinal level
Intervening variable. Composite score on the belief that the 2016 CDC guideline will
produce improved patient outcomes in relation to CNCP management (Belief)—
Ordinal level
Statistical tests. Mediation path analysis—Parametric
To determine whether the intervening variable was acting as a mediator between the
independent and dependent variables, the researcher performed a path analysis. Figure 5 presents
a schematic diagram of this path analysis.
For each of the first six research hypotheses promulgated in this study, an assumption
about the relationship between a pair of variables was proposed. None of these six hypotheses,
however, asserts causation between the variables or attempts to say that the value of one variable
can be used to predict the value of another variable. Therefore, PI used correlational tests—
including Pearson’s r to assess the reasonableness of these hypotheses.
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CHAPTER IV.
RESULTS
This chapter presents the results of the survey and further validates the survey tool for
construct validity and reliability.
Sample Characteristics
The total sample size was 143 primary care practitioners, as demonstrated by post hoc
power analysis conducted the G*Power. The age range varied from 25 to 69 years of age
reflecting resident eligible practitioners to semiretired practitioners. The sample revealed age
groups divided into nine categories. Most participants were in the 35–39 age (n=34, 22% of the
sample). The age groups of 30–34, 40–44, and 45–49 represented approximately near equal
percentages of the sample size, 15.72%, 18.87%, and 15.73%, respectively (See Table 3). These
demographic data indicate that most participants were young early practitioners, and the minority
of participants fell in the preretirement age category.
Regarding the CME-training portion of the study, the results indicated most participants
(43.5%) reported CME completion between 5 and 9 hours in the past 3 years. The next highest
frequency was 31.5% with 1–4 hours of CME completion. Post licensure training, in relation to
CME completion, is mandatory for licensure renewal; however, no uniform mandate exists for
CME dedicated to chronic-pain management.
For the portion of the demographics relating to highest level of education, the majority of
participants (102, 64%) of the sample had attained a master’s degree; 31% had obtained a
professional degree of medical doctorate (MD). The findings indicated that majority of the
sample comprised midlevel practitioners, as a master’s degree would provide the minimal entry
to practice.
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Table 3.
Participant Demographics
Age

CME Training

Education

Profession

Frequency

Percent

25–29

12

7.55

30–34

25

15.72

35–39

35

22.01

40–44

30

18.87

45–49

25

15.72

50–54

12

7.55

55–59

4

2.52

60–64

11

6.92

65–69

5

3.14

0 hours

5

3.10

1–4 hours

50

31.45

5–9 hours

66

41.51

10–19 hours

38

23.90

Master’s Degree

102

64.15

Doctorate Degree (EdD, PhD, PsyD)

8

5.03

Professional Degree (MD, DDS)

49

30.82

Physician

47

29.56

Physician Assistant (PA)

57

35.85

Nurse Practitioner (NP)

55

34.59

Table 3 Cont.
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Years of experience

2

10

6.29

3

19

11.95

4

15

9.43

5

17

10.69

6

16

10.06

7

13

8.18

8

9

5.66

9

12

7.55

10

12

7.55

11

4

2.52

12

1

0.63

13

1

0.63

14

2

1.26

15

1

0.63

18

2

1.26

19

3

1.89

20

6

3.77

22

3

1.89

23

2

1.26

24

1

0.63

26

1

0.63

27

2

1.26

28

3

1.89

30

1

0.63

31

1

0.63

33

1

0.63

37

1

0.63

Note. N = 143, CME = continuing medical education.

Exploring the professional status of respondents, participants had a near-equal
distribution among the three professions practicing primary care. Physicians represented 29.56%
of the sample, nurse practitioners represented 34.59%, and physician assistants represented
slightly higher at 35.85%. Participants’ years of experience varied greatly from a minimum of 2
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years’ experience and a maximum of 37 years. Participants with more than 10 years of
experience accounted for 30% of the sample.
Regarding geographic representation of participants, because the PI disseminated this
survey through Listservs of three national professional organizations, respondents represented a
wide number of states. The CDC divides geography of the 50 states and the District of Columbia
into 10 regions, loosely based on Department of Health and Human Services regions. The
intention was to strengthen the consistency and quality of the guidance, communications, and
technical assistance provided to states to improve coordination. Each region comprises four to
seven states. Of the total of 143 responders, the highest number (44, 27.68%) were from the
southeastern region or Region 4, which includes Alabama, Florida, Georgia, Kentucky,
Mississippi, North Carolina, South Carolina, and Tennessee. Table 4 provides the regions and
number of responders from that region.
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Table 4
Responses by Region

Region

State

N

Region 1

Connecticut, Massachusetts, New
Hampshire, Rhode Island, Vermont

Region 2

New Jersey, New York

Region 3

%
18

11.31

9

5.66

Delaware, District of Columbia,
Maryland, Pennsylvania, Virginia, West
Virginia

12

7.54

Region 4

Alabama, Florida, Georgia, Kentucky,
Mississippi, North Carolina, South
Carolina, Tennessee

44

27.68

Region 5

Illinois, Indiana, Michigan, Minnesota,
Ohio, Wisconsin

18

11.32

Region 6

Arkansas, Louisiana, New Mexico,
Oklahoma, Texas

8

5.04

Region 7

Iowa, Kansas, Missouri, Nebraska

9

5.67

Region 8

Colorado, Montana, North Dakota, South
Dakota, Utah, Wyoming

13

8.18

Region 9

Arizona, California, Hawaii, Nevada

15

9.43

Region 10

Alaska, Idaho, Oregon, Washington

12

8.17

Instrument Validation
Validity of an instrument is the degree to which it measures what it is supposed to
measure (Field, 2018). The team of authors on the CDC writing committee subjected the
instruments used in this study to face validity. To further test the construct validity of the
instrument, the researcher ran factor analysis for the two practice scales, the attitude scale, and
belief scale (Field, 2018). Factor analysis explores the relationship of multiple observed variables
have similar patterns of responses because they are all associated with a latent variable (Field,
2018). Latent variables are variables that researchers do not directly observe but rather infer
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them from other variables. Factor loading indicate the extent of relevance or relationship of
variables in explaining a construct. As a rule of thumb, a 0.7 or higher factor loading represents
that the factor extracts sufficient variance from that variable (Field, 2018).
The PI ran a series of EFAs with a varimax (orthogonal) rotation and a cut off 1.25 for
eigenvalue to align with the component. An eigenvalue is a measure of how much of the
variance of the observed variables the factor explains. For a factor to be considered loading
cleanly, it needs to have loaded at least .13 higher on a factor. Table 5 displays factor loading
that could load freely. All but one question located cleanly for the first factor for the belief
variables. For individual attitudes, several also loaded on the first factor as well as one of the
second factors and one on the fourth factor. For individual attitudes, several also loaded on the
first factor as well as one of the second factors and one on the fourth factor. For Practice I (Harm
Reduction), six items loaded on Factor 2, two items loaded on Factor 3, and one item on Factor
4. Three questions did not load cleanly on any factor.
The PI then forced a three-factor solution to see if different results emerged (see Table 6).
In the forced three-factor solution, the belief scale remained the same with all but one statement
loading cleanly on Factor 1: Belief Statement 6. All but three individual attitudes loaded cleanly
on Factor 1; Attitudes Items 6 and 1 loaded on Factor 3, and 9 did not load cleanly at all. Practice
Statements 1–6 and 16 loaded on Factor 3; Practice Statements 8–15 loaded on Factor 2, and
Practice Statement 7 did not load cleanly.
Recognizing that these factors did not load cleanly when all the variables were included
together, the PI chose to run several different factor analyses to investigate how each scale item
loaded when they were not with the other scale. The following analysis attempts to examine
factor loadings separately.
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Table 5
Free Loading Exploratory Factor Analysis

Component
1

2

3

4

Belief 1

0.807

0.388

0.125

-0.064

Belief 2

0.818

0.373

0.116

-0.007

Belief 3

0.802

0.402

0.178

0.084

Belief 4

0.748

0.428

0.181

0.074

Belief 5

0.709

0.456

0.233

0.105

Belief 6

0.506

0.523

0.003

0.332

Individual attitudes 1

0.399

0.357

0.193

-0.342

Individual attitudes 2

0.804

0.202

0.277

-0.067

Individual attitudes 3

0.794

0.137

0.369

-0.037

Individual attitudes 4

0.745

0.012

0.228

-0.250

Individual attitudes 5

0.742

0.128

0.447

0.052

Individual attitudes 6

0.405

0.279

0.231

0.593

Individual attitudes 7

0.722

0.130

0.479

0.047

Individual attitudes 8

0.711

0.015

0.414

-0.067

Individual attitudes 9

0.451

0.186

0.544

0.054

Individual attitudes 10 -0.180

0.153

0.171

0.760

Practices 1

0.394

0.727

0.262

0.128

Practices 2

0.379

0.759

0.320

0.127

Practices 3

0.200

0.781

0.376

0.075

Practices 4

0.253

0.729

0.440

0.105

Practices 5

0.168

0.764

0.343

0.176

Practices 6

0.149

0.688

0.273

0.217

Practices 7

0.316

0.313

0.339

-0.367

Practices 8

0.206

0.444

0.611

0.269

Practices 9

0.280

0.450

0.691

0.113
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Table 5 continued

Practices 10

0.298

0.543

0.585

0.175

Practices 11

0.212

0.484

0.679

0.073

Practices 12

0.261

0.345

0.685

0.092

Practices 13

0.212

0.385

0.702

0.109

Practices 14

0.311

0.139

0.746

0.018

Practices 15

0.247

0.179

0.673

0.017

Practices 16
-0.057
0.320
Note. a. Rotation converged in 10 iterations.

0.104

0.730

Table 6
Forced 3-Factor Exploratory Factor Analysis

Component
1

2

3

Belief 1

0.848

0.170

0.262

Belief 2

0.846

0.150

0.289

Belief 3

0.816

0.203

0.369

Belief 4

0.768

0.213

0.380

Belief 5

0.728

0.265

0.419

Belief 6

0.501

0.027

0.622

Individual attitudes 1

0.500

0.282

0.043

Individual attitudes 2

0.816

0.287

0.116

Individual attitudes 3

0.790

0.363

0.084

Individual attitudes 4

0.768

0.236

-0.148

Individual attitudes 5

0.719

0.427

0.133

Individual attitudes 6

0.313

0.176

0.604

Individual attitudes 7

0.701

0.460

0.130

Individual attitudes 8

0.697

0.394

-0.030

Individual attitudes 9

0.443

0.540

0.168

Individual attitudes 10

-0.303

0.092

0.609
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Table 6 Continued
1

2

3

Practice Attitudes 1

0.455

0.345

0.629

Practice 2

0.444

0.407

0.650

Practice 3

0.282

0.478

0.626

Practice 4

0.319

0.527

0.607

Practice 5

0.230

0.431

0.681

Practice 6

0.195

0.345

0.653

Practice 7

0.415

0.423

-0.013

Practice 8

0.198

0.625

0.496

Practice 9

0.300

0.724

0.397

Practice 10

0.321

0.627

0.511

Practice 11

0.246

0.725

0.394

Practice 12

0.271

0.704

0.304

Practice 13

0.225

0.727

0.344

Practice 14

0.304

0.739

0.100

Practice 15

0.249

0.676

0.130

0.055

0.719

Practice 16
-0.153
Note. a. Rotation converged in 7 iterations.

Belief Scale
The PI ran an EFA to explore if all six question items would load on a single factor
cleanly. The results of the EFA showed Belief did load on a single factor (see Table 7). The total
variance explained was 70%, which is a strong correlation across variables. The reliability
statistics of the Cronbach’s alpha coefficient 0.944 signaled a strong correlation across variables.
A Cronbach’s alpha coefficient of 0.7 or higher signifies high internal consistency.
EFA Results for Belief. The researcher ran an EFA to test whether all components were
significant predictors of Belief. As shown in Table 7 Item 6, although still a significant predictor,
is weaker than the other five variables. An EFA was run with just the five items and, as shown in
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Figure 6, all items are strong predictors. Therefore, it was decided to eliminate Item 6 and have
five-item Belief scales, as demonstrated in Table 8.

Table 7.
EFA With 6 Items in Belief and corresponding Eigen Values
Component
Belief 1
Belief 2
Belief 3
Belief 4
Belief 5
Belief 6

<--<--<--<--<--<---

Belief
Belief
Belief
Belief
Belief
Belief

0.907
0.922
0.945
0.909
0.914
0.732

B
1
1.013
1.102
0.956
1.044
0.841

S.E.

Beta

0.056
0.057
0.059
0.066
0.091

0.897
0.923
0.948
0.887
0.877
0.654

Figure 6. Exploratory Factor Analysis with Five Items on the Belief Scale
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p
***
***
***
***
***

Table 8.
Exploratory Factor Analysis Standardized Regression Weights: Belief

B

S.E.

Beta

p

Belief 1

<---

Belief

1

0.902

Belief 2

<---

Belief

1.013

0.055

0.929

***

Belief 3

<---

Belief

1.094

0.056

0.947

***

Belief 4

<---

Belief

0.947

0.058

0.883

***

Belief 5

<---

Belief

1.029

0.066

0.869

***

Individual Attitudes Scales
For the Individual Attitude scale, the researcher ran an EFA and found a two-factor
solution. The PI further explored for the elimination of potential variables to create a better scale.
The first factor accounted for 54.8% of the variance and the second accounted for 14.3% of the
variance. For the two-factor loading, the Cronbach’s α = 0.869 signified a very strong
correlation. In a more detailed examination to improve the scale, a trial removal of Attitudes
Item 10 resulted in the items converging around a single factor. The researcher constructed the
Cronbach’s alpha α = 0.909 and thus the variable with just Items 1–9 (see Table 9).
The PI ran an EFA to see how well the nine items predicted the latent variable of the
Individual Attitudes Scale. All variables were significant at the p < 0.001 level. Thus, the
Individual Attitude Scale was constructed with nine items (see Figure 7).
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Table 9.
Eigen Values for Items in Individual Attitudes Scale

Component
1

2

Individual attitudes 1

0.574

-0.074

Individual attitudes 2

0.884

0.059

Individual attitudes 3

0.907

0.087

Individual attitudes 4

0.810

-0.234

Individual attitudes 5

0.881

0.170

Individual attitudes 6

0.418

0.729

Individual attitudes 7

0.846

0.230

Individual attitudes 8

0.815

0.037

Individual attitudes 9

0.663

0.245

Individual attitudes 10
Note. N = 143.

-0.197

0.873

Figure 7. Individual Attitude Scale
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Practice
The PI ran an EFA to test how Practices aligned. Items loaded on two factors. The first
accounted for 58.7% of the variance and the second accounted for 8.9% of the variance. Four
questions did not cleanly load on either. It was decided to break this into two scales, the first with
Questions 1–11 and 16 (Practice Scale 1), and the second Questions 8–15 (Practice Scale 2).
After splitting the scales, both scales loaded on a single factor. Practice Scale 1 accounted for
62% of the variance and had a Cronbach’s α = 0.906. Practice Scale 2 accounted for 68% of the
variance and had a Cronbach’s α = 0.931 (see Table 10).

Table 10
Eigen Values for Items in Individual Attitudes Scale
1

2

Practice 1

0.772

0.350

Practice 2

0.782

0.421

Practice 3

0.792

0.378

Practice 4

0.759

0.458

Practice 5

0.787

0.345

Practice 6

0.703

0.289

Practice 7

0.073

0.628

Practice 8

0.586

0.552

Practice 9

0.563

0.664

Practice 10

0.664

0.569

Practice 11

0.566

0.636

Practice 12

0.476

0.630

Practice 13

0.478

0.659

Practice 14

0.204

0.803

Practice 15

0.159

0.769

Practice 16

0.705

-0.226

Note. N = 143.
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Practice Scale 1: Harm Reduction. All factors were significant for the Practice Scale 1
(see Table 11). Figure 8 shows the factor analysis using AMOS software. The circle represents
the latent variable; rectangles represent measure variables standardized regression (Betas)
weights indicated on the corresponding arrows, which indicate the strength of factor loading.

Table 11
Exploratory Factor Analysis Standardized Regression Weights: Practice Scale 1

B

S.E.

Beta

p

Practice 2

<---

PA1

1.084

0.065

0.928

***

Practice 3

<---

PA1

1.006

0.065

0.898

***

Practice 4

<---

PA1

1.049

0.072

0.869

***

Practice 5

<---

PA1

0.909

0.066

0.848

***

Practice 6

<---

PA1

0.807

0.08

0.705

***

Practice 7

<---

PA1

0.376

0.079

0.387

***

Practice 16

<---

PA1

0.402

0.086

0.38

***

Practice 1
Note. N = 143.

<---

PA1

1

0.875
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Figure 8. Practice Scale I Reduce Harm Exploratory Factor Analysis

Practice Scale 2. All factors were significant for Practice Scale 2 Other Modalities (see
Table 12). Figure 6 shows factor analysis using analysis of SPSS AMOS software. The circle
represents latent variables and rectangles represent observable variables standardized regression
(betas). Weights are indicated with the corresponding arrows, which indicate the strength of
factor loading (Figure 9).
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Table 12
Exploratory Factor Analysis Standardized Regression Weights: Practice Scale 2

B

S.E.

Beta

p

Practice 8

<---

PA2

1

0.797

Practice 9

<---

PA2

0.961

0.077

0.89

***

Practice 10

<---

PA2

0.954

0.078

0.879

***

Practice 11

<---

PA2

0.955

0.081

0.854

***

Practice 12

<---

PA2

0.889

0.084

0.786

***

Practice 13

<---

PA2

0.889

0.082

0.801

***

Practice 14

<---

PA2

0.84

0.091

0.712

***

Practice 15
Note. N = 143.

<---

PA2

0.666

0.085

0.623

***

Figure 9. Practice Scale 2 Other Modalities Exploratory Factor Analysis
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Descriptive Statistics
Table 13 represents descriptive statistics for the constructed scales. Practice Scale II scale
represents efforts to increase use of alternate nonopioid modalities. Ranges for skewness used in
the analysis were -3 to 3 and ranges for kurtosis were -1 to 1. All scales were normally
distributed, as neither skewness nor kurtosis was out of range of normal distributions.

Table 13
Descriptive Statistics Analysis

Skewness
-3 to 3

Kurtosis
-1 to 1

Mean

SD

Min

Max

Statistic

Std.
error

Std.
Statistic error

Knowledge

77.55

12.90

30.00

100.00

-0.83

0.20

0.813

0.403

Belief Scale

5.20

1.44

1.80

8.40

-0.25

0.20

-0.416

0.403

Individual
Attitude Scale

4.74

0.93

2.11

7.11

-0.42

0.20

0.233

0.403

Practice 1
Reduce Harm

6.35

1.07

3.25

9.00

0.09

0.20

0.192

0.403

Practice 2 Other 5.33
modalities

1.04

3.13

8.63

0.29

0.20

0.225

0.403

Inferential Statistics
The PI conducted bivariate analysis in SPSS for Research Questions 1–4.
Years of Experience Impact on Knowledge, Belief, and Attitude
Research Q 1. What is the relationship between the amount of providers’ years of
experience and (a) provider’s knowledge of the 2016 CDC Guideline, (b) provider’s
belief that the 2016 CDC Guideline will reduce the epidemic opioid crisis, and (c)
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provider’s attitude toward the implementation of the 2016 CDC Guideline will
produce improved outcomes with regard to CPM?
H1a: There is a positive relationship between the provider’s years’ experience and the
provider’s knowledge of the current CDC Guideline.
A statistically significant bivariate relationship emerged between years of experience and
knowledge (r = -.217, p = 0.09). As years of experience increased, knowledge decreased (see
Table 15).
Table 15
Bivariate Analysis
CME

Knowledge Belief Scale Individual Practice 1 Practice 2
Attitude
Reduce
Other
Scale
Harm
Modalities
-.217**

-.657**

-.583**

-.392**

-.375**

p 0.126

0.009

0.000

0.000

0.000

0.000

r

.204*

0.075

0.099

.174*

0.148

p

0.014

0.372

0.241

0.038

0.078

r

.294**

.372**

.289**

.284**

p

0.000

0.000

0.000

0.001

r

.831**

.659**

.631**

p

0.000

0.000

0.000

Individual Attitude r
Scale

.620**

.700**

p

0.000

0.000

Years of Training r
CME
Knowledge
Belief Scale

Practice Reduce
Harm

0.129

.789**

r

p
Note. CME = continuing medical education.

0.000
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H1b: There is a positive relationship between the provider’s years’ experience and the
provider’s attitude that that the 2016 CDC guideline will reduce the epidemic opioid
crisis in relation to CPM.
A statistically significant relationship emerged between a provider’s years of experience
and the provider’s attitude that the 2016 CDC Guideline would reduce the epidemic opioid crisis
in relation to CME (r = -0.657, p < 0.001). As years of experience increased, a provider’s belief
that the 2016 CDC Guideline would reduce the epidemic opioid crisis decreased.
H1c: There is a positive relationship between the provider’s years’ experience and the
provider’s belief that the implementation of the current CDC Guideline will produce
improved patient outcomes about CPM.
A statistically significant relationship emerged between a provider’s years of experience
and the provider’s belief that the implementation of the 2016 CDC Guideline would produce
improved patient outcomes in CPM (r = -.583, p < 0.001). As years of experience increased, a
provider’s belief that the implementation of the 2016 CDC guideline would produce improved
patient outcomes about CPM decreased.
CME Training Impact on Knowledge, Belief, and Individual Attitude
Research Question 2. What is the relationship between the amount of provider’s post
licensure training (CME) in the area of CPM and (a) provider’s knowledge of the
2016 CDC Guideline, (b) provider’s belief that the 2016 CDC Guideline will reduce
the epidemic opioid crisis, and (c) provider’s attitude that the implementation of the
2016 CDC Guideline will produce improved outcomes with regard to CPM?
H2a :There is a positive relationship between the amount of provider’s CME in the area of
CPM and the provider’s knowledge of the 2016 CDC Guideline.
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A statistically significant bivariate relationship emerged between a provider’s CME hours
in CPM and the provider’s knowledge of the 2016 CDC Guideline (r = 0.204, p = 0.059). As a
provider’s post licensure training hours increased, knowledge of 2016 CDC Guideline increased.
H2b: There is a positive relationship between the amount of provider’s CME in the area of
CPM and the provider’s belief that that the current CDC Guideline will reduce the
epidemic opioid crisis in relation to CPM.
No statistically significant bivariate relationship arose between a provider’s CME hours
in the area of CPM and the provider’s belief that that the current CDC Guideline would reduce
the epidemic opioid crisis in relation to CPM (r = .075, p =0 .372). As a provider’s post
licensure training hours increased, they experienced no change in knowledge of the 2016 CDC
guidelines.
H2c: There is a positive relationship between the amount of provider’s CME in the area of
CPM and the provider’s attitude that the implementation of the current CDC
Guideline will produce improved patient outcomes.
No statistically significant relationship arose between the amount of a provider’s CME
hours in the area of CPM and the provider’s attitude that the implementation of the 2016 CDC
Guideline would produce improved patient outcomes (r = .099, p > 0.05). As a provider’s post
licensure training hours increased, no change occurred in the provider’s attitude that the
implementation would improve patient outcomes.
Knowledge Impact on Belief and Attitude
Research Q3. What is the relationship between the provider’s knowledge of the 2016
CDC Guideline and (a) the provider’s belief that the 2016 CDC Guideline will reduce
the epidemic opioid crisis in relation to CPM and (b) The provider’s attitude that the
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implementation of the most current CDC Guideline will produce improved outcomes
with regard to CPM?
H2a : There is a positive relationship between the provider’s knowledge of the 2016 CDC
Guideline and the provider’s belief that the CDC Guideline will reduce the epidemic
opioid crisis.
A statistically significant bivariate relationship emerged between knowledge and a
provider’s belief that the guidelines would reduce the opioid crisis (r = 0.294, p < 0.001). As a
provider’s knowledge of the guidelines increases, a commensurate increase arose that the
guidelines would reduce the opioid crisis.
H2b: There is a positive relationship between the provider’s knowledge of the 2016 CDC
Guideline and the provider’s attitude that the implementation of the guideline will
produce improved patient outcomes.
A significant bivariate relationship emerged between knowledge of the guidelines and
attitude in that implementation of the guidelines would improve patient outcomes (r = 0.372, p <
0.001). As provider’s content knowledge of the guidelines increased, the provider’s individual
attitudes regarding implementation of the guidelines also increased.
Belief Impact on Individual Attitude
Research Q 4. What is the relationship between the provider’s belief that the 2016 CDC
Guideline will reduce the epidemic opioid crisis in relation to CPM and the provider’s
attitude of the implementation of the CDC Guideline will produce improved
outcomes with regard to CPM?
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H3: There is a positive relationship between the provider’s belief that the CDC Guideline
will reduce the epidemic opioid crisis and provider’s attitude that the implementation
of the 2016 guidelines will produce improved outcomes about CPM.
A statistically significant bivariate relationship emerged between belief and individual
attitude (r = 0.831, p < 0.001). Aligned with an increase on the belief scale, a provider’s
individual attitude scale score increased regarding implementation of the guidelines to improve
patient outcomes.
Path Analysis
Structural equation modeling is a statistical analysis method that uses a multivariate
approach to analyze structural relationships. Structural equation modeling includes factor
analysis and multiple regression analysis, incorporating measured variables and latent constructs.
Knowledge—Belief- Practice
Research Q 5. Do either of the following variables act as mediators between the
provider’s knowledge of the 2016 CDC Guideline and the provider’s attitude
regarding the implementation of the 2016 CDC Guideline in their own practice?
a) The provider’s belief that the 2016 CDC Guideline will reduce the epidemic
opioid crisis in relation to CPM.
b) The provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved patient outcomes with regard to CPM.
H4a The provider’s belief that the 2016 CDC Guideline will reduce the epidemic opioid
crisis in relation to CPM acts as a mediator between the provider’s knowledge of the
2016 CDC Guideline and the provider’s attitude regarding the implementation of the
2016 CDC Guideline recommendations in their own practice.
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Knowledge—IA-Practice
H4b The provider’s belief that the implementation of the 2016 CDC Guideline will
produce improved patient outcomes in CPM acts as a mediator between a provider’s
knowledge of the 2016 CDC Guideline and the provider’s attitude regarding the
implementation of the 2016 CDC Guideline recommendations in their own practice.
The proposed model in the methodology section included all the main variables plus
practice years, CME, and doctor or physician assistant. After running the proposed model, I
discovered that goodness of fit results did not align with a good fit model. I reevaluated the
model to make the model stronger. The results of this initial run appear in Table 14.

76

Table 14
Path Results

B

S.E.

Beta

p

Knowledge

<---

Training

-0.369

0.139

-0.217

.008

Belief Scale

<---

Knowledge

0.018

0.007

0.159

.012

IA Scale

<---

Knowledge

0.019

0.005

0.258

***

IA Scale

<---

Training

-0.064

0.008

-0.527

***

Belief Scale

<---

Training

-0.118

0.012

-0.623

***

Harm

<---

Knowledge

0.005

0.005

0.06

.374

Modalities

<---

Knowledge

0.001

0.005

0.014

.831

Harm

<---

Belief Scale

0.343

0.082

0.473

***

Modalities

<---

IA Scale

0.621

0.123

0.558

***

Modalities

<---

Belief Scale

0.111

0.078

0.155

.153

Harm

<---

IA Scale

0.206

0.131

0.183

.115

Harm

<---

CME

0.138

0.082

0.107

.091

Modalities

<---

CME

0.103

0.077

0.081

.179

Harm

<---

Doctor

-0.115

0.166

-0.051

.489

Modalities

<---

Doctor

-0.006

0.157

-0.003

.968

Harm

<---

PA

-0.038

0.157

-0.017

.809

Modalities
<--PA
0.071
0.148
0.033
.634
Note. IA = Individual Attitude, CME = continuing medical education, PA = physician assistant.

To improve the model, the following steps were performed based on the suggestions from
AMOS about improving the model: Using the modification indices, the researcher connected
Error 1 (e1) to Error 4 (e4) and ran the model again. Goodness of fit results were still
unsatisfactory, such that X2 was 177.78, p < 0.001, root mean square error of approximation
(RMSEA) was 0.363, and confirmatory fit index (CFI) was 0.720. Modification indices also
indicated that elimination of the nonsignificant variables might the improve overall fit.
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The model had several nonsignificant variables. A stepwise approach to eliminating
nonsignificant variables of physician assistants, doctor, and CME impacted the model fit. Model
statistics resulted in X2 (2) = 1.948, p = 0.378, RMSEA = .00. This outcome might be explained
due to the X2 being less than the degrees of freedom in the model, which is 2. Any further
manipulation in the model would yield a significant X2 and an RMSEA would have a high value.
Therefore, this was the best model achievable.
Direct Results
Knowledge was a significant predictor of the Belief Scale, Beta = 0.16, p = 0.002. As the
knowledge variable increased, the belief variable also increased. Knowledge was a significant
predictor of the individual attitude scale, Beta = 0.26, p < 0.001. As knowledge increased, scores
on the individual attitude scale increased. Knowledge did not directly predict either of the
practice variables (Practice Scale I or Practice Scale II).
Belief was a significant predictor of Practice Scale I (harm reduction), Beta = 0.47, p <
0.001. As a provider’s belief increased, their Practice Scale (harm reduction) increased.
However, belief was not a predictor for Practice Scale II (using nonopioid modalities). Individual
attitude was a significant predictor of harm reduction, Beta = 0.20, p = 0.008. As individual
attitude increased, practicing attitudes of harm reduction also increased.
Individual attitudes were a significant predictor of Practice Scale in using nonopioid
modalities, Beta = 0.56, p < 0.001. As individual attitude increased, a provider’s practice of
using nonopioid modalities also increased. Knowledge effects were completely mediating
through individual attitude and belief. This makes a clear illustration that knowledge alone does
not signal practice behavior. The subjective construct of belief and respective attitude influence
the manner which provider practices. This may have impact on rejection or acceptance of given
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knowledge and consequent utilization of guidelines. As practitioners are individuals with strong
beliefs and personal experiences, they represent positive or negative attitudes despite learned
knowledge which impact practice. Indirect effect on harm was Beta = 0.126 and its indirect
effects on Modalities was Beta = 0.169. See Table 15 and Figure 10.

Table 15
Received Path Model Direct Results

DV

IV

B

S.E.

Beta

p

Belief Scale

<---

Knowledge 0.018

0.007

0.159

.012

Belief Scale

<---

Training

0.012

-0.623

***

Harm

<---

Knowledge 0.006

0.006

0.076

.252

Harm

<---

Belief
Scale

0.347

0.083

0.469

***

Harm

<---

IA Scale

0.232

0.132

0.201

.08

IA Scale

<---

Knowledge 0.019

0.005

0.258

***

IA Scale

<---

Training

-0.064

0.008

-0.527

***

Knowledge

<---

Training

-0.369

0.139

-0.217

.008

Modalities

<---

Knowledge 0.002

0.005

0.03

.641

Modalities

<---

IA Scale

0.124

0.556

***

-0.118

0.626

Belief
0.116
0.078
0.16
.135
Scale
Note. DV = dependent variable, IV = independent variable, IA = Individual Attitude.
Modalities

<---
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Figure 10. Final Path Model

Statistical Analysis for Each Quantitative Research Question

Summary
Table 16 presents a summary of findings for this project. Of the 11-hypothesis given,
only four were found lead to a failure to reject the null hypothesis.
Table 16.
Summary of Hypothesis Testing

Reject
H1a :There is no statistically significant relationship between the amount
of provider’s post-licensure training in the area of CPM and the
provider’s knowledge of the 2016 CDC Guideline.
H1b: There is no statistically significant relationship between the amount
of provider’s post-licensure training in the area of CPM and the
provider’s belief that that the 2016 CDC Guideline will reduce the
epidemic opioid crisis in relation to CPM.
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Fail to
Reject

X

X

H1c: There is no statistically significant relationship between the amount
of provider’s post-licensure training in the area of CPM and the
provider’s belief that the implementation of the 2016 CDC Guideline
will produce improved outcomes in CPM.
H2a: There is no statistically significant relationship between the amount of
provider’s years’ experience and provider’s knowledge of the 2016 CDC
Guideline.
H2b: There is no statistically significant relationship between the amount
of provider’s years’ experience and the provider’s individual attitude hat
that the 2016 CDC Guideline will reduce the epidemic opioid crisis in
relation to chronic pain management.
H2c: There is no statistically significant relationship between the amount
of provider’s years’ experience and the provider’s belief that the
implementation of the 2016 CDC Guideline will produce improved
outcomes in the area of CPM.
H3a: There is no statistically significant relationship between the
provider’s knowledge of the 2016 CDC guidelines and the provider’s
belief that that the CDC Guidelines will reduce the epidemic opioid
crisis in relation to CPM.
H3b: There is no statistically significant relationship between the
provider’s knowledge of the 2016 CDC Guidelines and the provider’s
belief that the implementation of the2016 CDC Guideline will produce
improved outcomes in CPM.
H4: There is no statistically significant relationship between the
provider’s belief that the 2016 CDC Guideline will reduce the epidemic
opioid crisis in relation to CPM and the provider’s belief that the
implementation of the 2016 CDC Guideline will produce improved
outcomes.
H5a: The provider’s belief that the 2016 CDC Guideline will reduce the
epidemic opioid crisis in relation to CPM acts as a mediator between the
provider’s knowledge of the 2016 CDC Guideline and the provider’s
attitude regarding the implementation of the 2016 CDC Guideline
recommendations in his or her own practice.
H5b: The provider’s belief that the implementation of the 2016 CDC
Guideline will produce improved patient outcomes in CMP acts as a
mediator between the provider’s knowledge of the 2016 CDC Guideline
and the provider’s attitude regarding the implementation of the 2016
CDC Guideline recommendations in his or her own practice.
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X

X

X

X

X

X

X

X

X

CHAPTER V
DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS
Discussion
The CDC released the Guideline for Prescribing Opioids for Chronic Pain in 2016. The
CDC Guideline recommendations revealed much confusion and resistance from patientadvocacy groups and medical providers. To date, the guidelines remain unrevised and few peerreviewed publications describe factors that impede the engagement of primary care providers in
fully using these guidelines. The purpose of this analysis was to assess foundational constructs of
knowledge, beliefs, and attitudes in the CDC opioid prescribing guidelines. Understanding
perspectives from a primary care provider lens may help demystify the hesitancy in
incorporating the guidelines in their respective practices.
Key Findings
CME Training Impact on Knowledge, Belief, and Individual Attitude
This study assessed the relationship between primary care providers’ knowledge, beliefs,
attitudes, and practices with specific recommendations made by CDC’s 2016 opioid prescribing
clinical guidelines. It would be logical to expect a strong positive correlation between these
variables and practice behaviors. However, not all variables proved to have a positive impact on
outcome variables of practice. Davis and Taylor-Vaisey (1997) concluded CME activities are the
basis on which gains in knowledge lead physicians to improve their practices and thereby deliver
improved patient outcomes. However, majority of physicians failed to embrace the guidelines,
leaving a gap between the reality of practice and the ideal practice. Study findings similarly
showed a statistically significant positive bivariate relationship between providers’ CME hours
in the area of CPM and providers’ knowledge of the 2016 CDC Guideline (r = .204, p < 0.014).
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However, the correlation is a weak one, signaling a lesser likelihood of adherence to 2016 CDC
Guideline for opioid prescribing. Study results also showed no statistically significant
relationship between provider’s CME hours in area of CPM and the provider’s belief that the
current CDC Guideline will reduce the epidemic opioid crisis in relation to CPM (r = 0.075, p >
0.05). As belief constructs closely interlink with attitude constructs, this study also showed
consistently that no statistically significant relationship exists between the number of a
provider’s CME hours in the area of CPM and the provider’s attitude that the implementation of
the 2016 CDC Guideline would produce improved patient outcomes (r = 0.099, p > 0.05).
This study did not differentiate between specific guidelines relating to opioid
management and other types of CME relating to generic pain management. To date, only two
states require sizable CME hours specific to opioid prescribing—California and Kentucky (12
credit hours)—but the remaining states have minimal to no required hours relating to opioid
prescribing guidelines. In this study, 61 of 143 participants, or 43%, reported 5–9 hours of CME
achieved in the past 3 years. Another 31 (22%) of participants reported 10–19 hours of CME
completed in the past 3 years. Last, only 5, or 3.5%, of participants reported minimal continuing
medical education in CPM. It is plausible that study participants conflated the answer of CME
hours with other CMEs not specific to opioid prescribing.
McMalmot’s (2018) study divided the sample into three CME groups: minimal (0–3)
hours, moderate (4–10) hours, and high (≥ 11) CME hours of training. The three CME groups
aligned increased use of CDC opioid recommended practices (29.4, 34.2, 38.8, respectively; p =
0.001; scale 0–50) and confidence in pain management (5.5, 5.9, 6.9, respectively; p < 0.001,
scale 0–9). McMalmot concluded higher hours of continuing education positively impacted a
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provider’s confidence in pain management use of the CDC Guideline. I did not analyze the
variable of provider confidence in this study.
Years of Experience Impact on Knowledge, Belief, and Attitude
Limited literature examined a correlation between years of experience in practice and
practice outcomes. Benner (1984) defined experience as time in practice and self-reflection that
allows past leanings to be refined in real-time circumstances. Dryefus and Dryefus (1980)
developed the concept of a novice with less than 3 years’ experience, thereafter, rising to an
expert status with greater than 10 years of experience. The team elaborated that novice
professionals rely highly on rules and guidelines and as they mature to the level of expert, adhere
less to regimented rules and make more intuition-based decisions. This paradigm applied to the
medical profession would suggest that increased years in clinical experience should enhance
knowledge and thus clinical outcomes. Choudhry et al. (2005) conducted a meta-analysis of 62
empirical studies investigating the relationship between clinical experience and performance.
The study reported 32 of 62 (52%) evaluations showed decreasing performance with increasing
years in practice for all outcomes assessed. The researchers concluded that physicians with
greater years in practice and older physicians have less factual knowledge and were less likely to
adhere to standards of care or adopt newer guidelines. Similarly, this study showed a statistically
significant negative bivariate relationship between years of experience and knowledge
(r = -0.217, p < 0.05). This inverse relationship means as medical practitioners have increased
years of experience, they have decreased knowledge of the 2016 CDC opioid practice guidelines.
Additionally, a statistically significant negative relationship emerged between a
provider’s years of experience and the provider’s belief that the 2016 CDC Guideline would
reduce the epidemic opioid crisis in relation to CPM (r = -0.657, p < 0.001). Last, a statistically
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significant negative relationship emerged between a provider’s years of experience and the
provider’s attitude that the implementation of the 2016 CDC Guideline would produce improved
patient outcomes in CPM (r = -0.583, p < 0.001).
Unlike in physics and chemistry, medicine is a dynamic applied science. Like any
dynamic process, it requires learning, growth, and adaptation. Although years of experience is a
highly regarded and respected attribute, it should not discourage new learning and engagement in
current trends in quality measures to improve practice.
Knowledge Impact on Belief and Attitude
Knowledge is understanding or comprehension of information or facts through education.
Knowledge is regarded as an objective and cognitive construct (Pajares & Thompson, 1992).
Belief is a more subjective, experience-based, often implicit construct. Often, belief is affective
in nature (Thompson, 1992). More strongly held beliefs are more central, and weaker beliefs are
more “peripheral” (Green, 1971). The more central or the stronger a belief, the less it is
susceptible to change and thus impacts attitudinal behaviors. This study addressed the
relationship between a provider’s knowledge of the 2016 CDC Guideline and the provider’s
belief that the 2016 CDC Guideline would reduce the epidemic opioid crisis in relation to CPM
and, by extension, the provider’s attitude that the implementation of the 2016 CDC Guideline
would produce improved outcomes regarding CPM. The analysis revealed a statistically
significant positive bivariate relationship between knowledge and a provider’s belief that the
guidelines would reduce the opioid crisis (r = 0.294, p < 0.001). Thus, as knowledge scores
increased, a corresponding increase arose in the belief variable that the guidelines would
positively impact the opioid crisis by reducing the epidemic. Additionally, a statistically
significant positive relationship emerged between knowledge of the guidelines and attitude that
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implementation of the guidelines will improve patient outcomes (r = 0.372, p < 0.001). It follows
that a strong or centrally held belief will have an equally strong parallel impact on attitudinal
constructs and, in this case, attitude that the use of the guidelines would improve each individual
patient’s outcome.
No comparative study in the literature examined knowledge and its impact on belief that
guidelines would influence the reduction of the opioid epidemic, nor did any study investigate
attitudinal impact between knowledge and improved patient outcomes. In a prospective
longitudinal study, Jamison et al. (2014) surveyed 56 primary care practitioners on their beliefs
and attitudes about opioid prescribing and CPM and concluded that younger providers were less
knowledgeable about opioids, but opioid knowledge did not relate to concerns about opioid
prescription practices. The Jamison et al. study predated the 2016 CDC opioid prescribing
guidelines and was limited to a small sample size. Pearson et al. (2017) investigated provider
confidence levels in prescribing opioids to noncancer patients. Providers in that study (60.8%)
were not confident of their ability to manage chronic pain and their levels of confidence 1 year
after targeted intervention did not significantly improve (44.7%, p > 0.05). Many primary care
providers continued to lack confidence in managing pain patients and reported reluctance to
prescribe opioids for CNCP. This study supports knowledge impact on Practice Scales, as the
providers’ belief of confidence decreases their attitude toward prescribing practice decreases
despite increase in infused knowledge of intervention.
In examining the relationship between a provider’s belief that the 2016 CDC Guideline
would reduce the epidemic opioid crisis and a provider’s attitude on the implementation of the
CDC Guideline would produce improved patient outcomes, this study revealed a statistically
strong significant and positive bivariate relationship between belief and individual attitude on
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improved patient outcomes (r = 0.831, p < 0.001). As an increase arose in the belief scale, an
increase arose on the individual attitude scale regarding using the guidelines to improve patient
outcomes. As discussed earlier, the stronger a belief, the more the believer is resistant to change,
impacting the provider’s attitudinal behaviors.
Mediating Variables
Path analysis is a form of multiple regression statistical analysis that researchers use to
evaluate causal models by examining relationships between a dependent variable and two or
more independent variables. In this study, the PI found that belief has a mediating effect between
knowledge of the guidelines and providers’ Practice Scales. A provider’s belief that the 2016
CDC Guideline would reduce the epidemic opioid crisis in CPM acted as a mediator between the
provider’s knowledge of the 2016 CDC Guideline and the provider’s attitude regarding the
implementation of the 2016 CDC Guideline in their own practice. The provider’s belief that the
implementation of the 2016 CDC Guideline would improve outcomes of patients with CPM acts
as a mediator between the provider’s knowledge of the 2016 CDC Guideline and the provider’s
attitude regarding the implementation of the 2016 CDC Guideline in their own practice.
Therefore, the researcher failed to reject the null hypothesis because it hypothesized that
knowledge impacts on practice would be mediated by individual attitude and belief, supported by
path analysis. Last, although belief clearly mediated between knowledge and practice, attitude
did not mediate practice. This outcome leads to a thought-provoking conundrum that may lead to
exploration of granularity in attitudes in future studies.
Limitations of the Study
As with majority of studies, the design of the current study is subject to limitations.
The following are major limitations of this study that could be addressed in future research.
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1. Due to the contemporary nature of this study, exploring novel guidelines on opioid
prescribing, from a review of the literature, limited published research described
practitioner perspectives on the subject. Thus, the ability to identify a gap in the
literature and develop research questions was challenging.
2. This study focused on self-reported data on the 2016 publication of the CDC
Guideline for opioid prescribing. Self-reported data rarely can be independently
verified (Price & Murnan 2004). The data collection was completed in its entirety in
2019; thus, respondents may have had diminished recall of the specific guidelines or
may have been confused with more recent guidelines, such as state guidelines,
organizational guidelines, or even standards of care. Additionally, the measurement
of practice variable was not defined with standardized protocol. That is self-reported
practice variable may or may not reflect a gold standard, as uniformity among
practice is variable.
3. The sample was not randomized. A convenience sample is an inexpensive way to
ensure sufficient number for nonprobability samples; therefore, the population may
have been underrepresented (Portney & Watkins, 2009).
4. The study was conducted through a web-based online survey to ensure anonymity and
confidentiality. However, it is unknown how many members may have missed
capture due to limited to access to email or the internet.
5. The study design was limited to quantitative methods. Although using Likert-type
scales can provide an idea about how strongly a participant feels about a statement,
this study did not include a qualitative portion, where open-ended or leading
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questions might provide more in-depth responses, reflecting participants’ actual
feelings rather than being restricted by categories.

6. The design of this study was cross-sectional and, as a result, it was not possible to
determine causality. A longitudinal approach would provide more comprehensive
understanding of the subject matter and the corresponding relationship. However, due
to time constraints, this was not possible.
7. Selection bias: The data accrued from three professional organizations: American

Association of Nurse Practitioners, the American Association of Physician Assistants,
and the Academy of Family Practice Physicians. Organizational membership is not a
mandatory practice requirement. Therefore, the results or findings from this study
may not be generalized to practitioners who have chosen not to maintain active
membership to their prospective organization.
Clinical Relevance
Pain is a complex phenomenon and thus the problem has no single solution. General
practitioners have minimal preparation to manage complex pain-related issues without
appropriate guidelines. The limited number of specialists trained to manage challenging pain
patients places a great level of stress on primary care providers. A need exists for uniformity and
standardization in opioid prescribing practices. It is equally important that guidelines are in
alignment at the federal, state, and organizational levels. Overprescribing opioids has partly
contributed to opioid-related overdoses and fatalities. CDC’s mission to protect public health
places this authoritative body at the highest persuasive position to develop guidelines for
prescribing opioids. It is not sufficient for providers to become familiar with the 2016 CDC
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opioid-prescribing guidelines; they must retain the critical knowledge of the guidelines and use
the guidelines routinely. State boards of licensing should consider formal learning modules and
certificates of attestation for those with passing knowledge scores. Such learning modules could
be considered a prerequisite to obtaining and renewing Drug Enforcement Administration
registration. Physicians, as lead patient-safety advocates, should champion adoption of
prescribing guidelines and thus lead the movement for safe prescribing practices for their
colleagues and midlevel providers.
Future Research
Although this study adds to the existing body of knowledge regarding the 2016 CDC
Guideline relating to opioid prescribing for primary care providers, it also generates several
research questions to be explored for future research. The PI did not address characteristics of
clinical guidelines in this study. Other researchers documented that guidelines inherently
accompany barriers such as ease of use, trialability, and complexity (Cabana et al., 1999); these
barriers are known reasons for guideline adoption and compliance. Incorporating guideline
characteristics into the survey tool may also enhance study results and may further highlight
concerns from providers who adopt or reject clinical practice guidelines relating to opioid
prescribing practices. Moreover, future researchers can expand exploration of practitioner
characteristics of time, resources, or organizational support as well as constraints.
Although this study found no statistical difference in practitioner type and the
implementation of clinical guidelines; it may be prudent to study midlevel populations separately
to gain a better understanding of midlevel practices that may be untethered by scope-of-practice
restrictions. The knowledge component showed low knowledge scores on the 2016 CDC
guidelines; it would be revealing to further explore practitioner type and knowledge. For
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example, is there a difference in knowledge of midlevel practitioners engaged in urban practice
areas or areas of high opioid use versus midlevel practitioners in suburban or rural practice
settings. The sample for this study was sourced through membership in professional
organizations; expanding sample eligibility through recruitment of licensure boards may improve
generalizability of the results. Lastly, adding a qualitative portion to the survey tool may provide
more insightful understanding of participants’ hesitation in embracing 2016 CDC opioid
prescribing guidelines.
Conclusion
This study provides useful insights into factors that influence primary care clinician
intentions to adopt opioid prescription practices for chronic pain patients. Addressing factors
such as knowledge, attitudes, and beliefs can assist in encouraging implementation strategies to
positively affect primary care practitioners’ prescriptive behaviors. In this study, knowledge was
a significant predictor of belief and attitude regarding the value of 2016 CDC opioid prescribing
guidelines. However, increased knowledge did not directly predict practice intention to use the
guidelines to reduce patient harm or use nonopioid practices, as recommended by the guidelines.
Increased CME hours was a significant predictor of knowledge scores, belief, and attitudes. This
outcome suggests that to influence the practice of primary care physicians, it would be useful to
provide more educational activities and frequent reinforcement. In examining mediating
variables, knowledge effects were completely mediated by attitudes and beliefs. Future
investigation into the affective factors that influence motivation to integrate current practice
guidelines may demystify the reasons for resistance to guideline adoption.
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Appendix B:

Letter of solicitation and Implied Consent
Dear Colleague,
My name is Maria Adamian. I would like to invite you to participate in a research study
(Medical providers’ Knowledge and Belief in the Effectiveness of the Centers for Disease
Control and Prevention’s 2016 Guideline for Prescribing Opioids for Chronic Pain). I am a
doctoral student at the department of Interprofessional Health Sciences and Health
Administration, in the School of Health and Medical Sciences, Seton Hall University. I am
conducting this research as partial fulfillment of my PhD degree in Health Sciences.
What is the purpose of the study?
This study will explore Medical Providers’ Knowledge and Belief in the Effectiveness of the
Centers for Disease Control and Prevention’s 2016 Guideline for Prescribing Opioids for
Chronic Pain. In the climate of opioid crisis and escalated public health threat of increasing
opioid related mortality, this timely study will investigate factors that may influence
practitioners’ attitudes towards prescribing guidelines from federal agency. The factors that will
be explored are knowledge, attitude among primary care practitioners and their relationship to
daily practices.
Is participation voluntary?
Your participation in this study is entirely voluntary and anonymous. You may withdraw from
the study at any time without any penalty.
Clicking on the link below signifies your consent to participate in this study.
https://www.surveymonkey.com/r/TGJZXHJ.

How will the study date be handled?
All data from this study will remain confidential. All data will be stored in password protected
USB memory stick locked in a physical secure box. No other personnel will have access to the
USB content, and no data will be available electronically.
Is there any risk or any benefits to partaking in the study?
Seton Hall University
6/2007

105

There is no risk in completing the study questionnaire.
There is no direct benefit to the participant in completing the study. However, the results will
provide enlightenment relating to provider intention to adopt 2016 CDC opioid prescribing
guidelines.
Is there compensation for participation?
There is no compensation for participation in the research study.
What is the expected time commitment to complete the study?
An anticipated 15-20 minutes to complete the study.
How can I learn more information on the study?
As principal investigator, I may be contacted at any time for further discussion relating to the
study at Maria.Adamian@Shu.edu or (201)249-4151. Additionally, you may contact Seton Hall
IRB at email irb@shu.edu or phone (973) 313-6314.
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